10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

or

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to    

Commission file number: 001-37935

Acushnet Holdings Corp.

(Exact name of registrant as specified in its charter)

Delaware			45-2644353
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
333 Bridge Street	Fairhaven,	Massachusetts	02719
(Address of principal executive offices)			(Zip Code)

(800) 225-8500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock - $0.001 par value per share	GOLF	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

The registrant had 74,063,851 shares of common stock outstanding as of April 30, 2021.

ACUSHNET HOLDINGS CORP.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

TABLE OF CONTENTS

		Page No.
PART I.	FINANCIAL INFORMATION	5
Item 1.	Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	34
PART II.	OTHER INFORMATION	35
Item 1.	Legal Proceedings	35
Item 1A.	Risk Factors	35
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	36
Signatures		37

1

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the “safe harbor” created by that section. These forward-looking statements are included throughout this report, including in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. The forward-looking statements also reflect our current views with respect to the impact of the novel coronavirus (“COVID-19”) pandemic on our business, results of operations, financial position and cash flows. We have used the words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable” and similar terms and phrases to identify forward-looking statements in this report, although not all forward-looking statements use these identifying words.

The forward-looking statements contained in this report are based on management’s current expectations and are subject to uncertainty and changes in circumstances. We cannot assure you that future developments affecting us will be those that we have anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. We believe that these factors include:

•the duration and impact of the COVID-19 pandemic, which may precipitate or exacerbate one or more of the following risks and uncertainties;

•a reduction in the number of rounds of golf played or in the number of golf participants;

•unfavorable weather conditions may impact the number of playable days and rounds played in a given year;

•consumer spending habits and macroeconomic factors may affect the number of rounds of golf played and related spending on golf products;

•demographic factors may affect the number of golf participants and related spending on our products;

•changes to the Rules of Golf with respect to equipment;

•a significant disruption in the operations of our manufacturing, assembly or distribution facilities;

•our ability to procure raw materials or components of our products;

•a disruption in the operations of our suppliers;

•the cost of raw materials and components;

•currency transaction and translation risk;

•our ability to successfully manage the frequent introduction of new products or satisfy changing consumer preferences, quality and regulatory standards;

•our reliance on technical innovation and high-quality products;

•our ability to adequately enforce and protect our intellectual property rights;

•involvement in lawsuits to protect, defend or enforce our intellectual property rights;

•our ability to prevent infringement of intellectual property rights by others;

•changes to patent laws;

•intense competition and our ability to maintain a competitive advantage in each of our markets;

•limited opportunities for future growth in sales of certain of our products, including golf balls, golf shoes and golf gloves;

•our customers’ financial condition, their levels of business activity and their ability to pay trade obligations;

•a decrease in corporate spending on our custom logo golf balls;

•our ability to maintain and further develop our sales channels;

•consolidation of retailers or concentration of retail market share;

•our ability to maintain and enhance our brands;

•seasonal fluctuations of our business;

•fluctuations of our business based on the timing of new product introductions;

•risks associated with doing business globally;

•compliance with laws, regulations and policies, including the U.S. Foreign Corrupt Practices Act or other applicable anti-corruption legislation, as well as federal, state and local policies and executive orders regarding the COVID-19 pandemic;

•our ability to secure professional golfers to endorse or use our products;

•negative publicity relating to us or the golfers who use our products or the golf industry in general;

•our ability to accurately forecast demand for our products;

•a disruption in the service, or a significant increase in the cost, of our primary delivery and shipping services or a significant disruption at shipping ports;

2

•our ability to maintain our information systems to adequately perform their functions;

•cybersecurity risks;

•the ability of our eCommerce systems to function effectively;

•impairment of goodwill and identifiable intangible assets;

•our ability to attract and/or retain management and other key employees and hire qualified management, technical and manufacturing personnel;

•our ability to prohibit sales of our products by unauthorized retailers or distributors;

•our ability to grow our presence in existing international markets and expand into additional international markets;

•tax uncertainties, including potential changes in tax laws, unanticipated tax liabilities and limitations on utilization of tax attributes after any change of control;

•adequate levels of coverage of our insurance policies;

•product liability, warranty and recall claims;

•litigation and other regulatory proceedings;

•compliance with environmental, health and safety laws and regulations;

•our ability to secure additional capital at all or on terms acceptable to us and potential dilution of holders of our common stock;

•risks associated with acquisitions and investments;

•our estimates or judgments relating to our critical accounting estimates;

•terrorist activities and international political instability;

•occurrence of natural disasters or pandemic diseases, including the COVID-19 pandemic;

•our substantial leverage, ability to service our indebtedness, ability to incur more indebtedness and restrictions in the agreements governing our indebtedness;

•our use of derivative financial instruments;

•the ability of our controlling shareholder to control significant corporate activities, and that our controlling shareholder’s interests may conflict with yours;

•our status as a controlled company;

•the market price of shares of our common stock;

•our ability to maintain effective internal controls over financial reporting;

•our ability to pay dividends;

•our status as a holding company;

•dilution from future issuances or sales of our common stock;

•anti-takeover provisions in our organizational documents and Delaware law;

•reports from securities analysts; and

•other factors discussed under the heading "Risk Factors" in our most recent Annual Report on Form 10-K and in any other reports we file with the Securities and Exchange Commission (“SEC”), including this Quarterly Report on Form 10-Q.

These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements.

Any forward-looking statement made by us in this report speaks only as of the date of this report. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, investments or other strategic transactions we may make. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

Website Disclosure

We use our website (www.acushnetholdingscorp.com) as a channel of distribution of company information. The information we post through this channel may be material. Accordingly, investors should monitor this channel, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Acushnet Holdings Corp. when you enroll your e-mail address by visiting the “Resources” section of our website at https://www.acushnetholdingscorp.com/investors/resources. In addition, on our website, we post the following filings free of charge as soon as reasonably practicable after they are electronically filed with or furnished to the SEC: our annual reports on Form 10-K, our proxy statements, our quarterly reports on Form 10-Q, our current reports on

3

Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. The contents of our website are not, however, a part of this report.

4

PART I.       FINANCIAL INFORMATION

ITEM 1.      FINANCIAL STATEMENTS

INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	Page(s)
Unaudited Condensed Consolidated Financial Statements
Condensed Consolidated Balance Sheets (unaudited)	6
Condensed Consolidated Statements of Operations (unaudited)	7
Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)	8
Condensed Consolidated Statements of Cash Flows (unaudited)	9
Condensed Consolidated Statements of Shareholders’ Equity (unaudited)	10
Notes to Unaudited Condensed Consolidated Financial Statements	11

5

ACUSHNET HOLDINGS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

	March 31,		December 31,
(in thousands, except share and per share amounts)	2021		2020
Assets
Current assets
Cash, cash equivalents and restricted cash ($8,666 and $6,843 attributable to the variable interest entity ("VIE"))	$	113,047	$	151,452
Accounts receivable, net	387,507		201,518
Inventories ($11,046 and $13,830 attributable to the VIE)	330,165		357,682
Prepaid and other assets	92,343		89,155
Total current assets	923,062		799,807
Property, plant and equipment, net ($10,319 and $10,538 attributable to the VIE)	220,616		222,811
Goodwill ($32,312 and $32,312 attributable to the VIE)	213,555		215,186
Intangible assets, net	471,394		473,533
Deferred income taxes	66,697		80,060
Other assets ($2,220 and $2,239 attributable to the VIE)	73,558		75,158
Total assets	$	1,968,882	$	1,866,555
Liabilities, Redeemable Noncontrolling Interest and Shareholders' Equity
Current liabilities
Short-term debt	$	24,696	$	2,810
Current portion of long-term debt	17,500		17,500
Accounts payable ($5,714 and $8,702 attributable to the VIE)	125,865		112,867
Accrued taxes	54,575		40,952
Accrued compensation and benefits ($852 and $1,454 attributable to the VIE)	67,693		82,290
Accrued expenses and other liabilities ($3,467 and $3,699 attributable to the VIE)	108,468		101,260
Total current liabilities	398,797		357,679
Long-term debt	309,524		313,619
Deferred income taxes	3,797		3,821
Accrued pension and other postretirement benefits	121,811		121,929
Other noncurrent liabilities ($2,276 and $2,261 attributable to the VIE)	48,876		52,128
Total liabilities	882,805		849,176
Commitments and contingencies (Note 15)
Redeemable noncontrolling interest	97		126
Shareholders' equity
Common stock, $0.001 par value, 500,000,000 shares authorized; 75,847,208 and 75,666,367 shares issued	76		76
Additional paid-in capital	926,809		925,385
Accumulated other comprehensive loss, net of tax	(98,160)		(96,182)
Retained earnings	271,967		199,776
Treasury stock, at cost; 1,783,357 and 1,671,754 shares (including 355,341 and 299,894 of accrued share repurchases) (Note 10)	(49,830)		(45,106)
Total equity attributable to Acushnet Holdings Corp.	1,050,862		983,949
Noncontrolling interests	35,118		33,304
Total shareholders' equity	1,085,980		1,017,253
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$	1,968,882	$	1,866,555

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

ACUSHNET HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

	Three months ended March 31,
(in thousands, except share and per share amounts)	2021		2020
Net sales	$	580,885	$	408,741
Cost of goods sold	270,146		207,786
Gross profit	310,739		200,955
Operating expenses:
Selling, general and administrative	176,369		152,723
Research and development	12,329		13,220
Intangible amortization	1,972		1,956
Restructuring charges	—		11,628
Income from operations	120,069		21,428
Interest expense, net	3,616		4,123
Other expense, net	1,992		690
Income before income taxes	114,461		16,615
Income tax expense	27,834		7,640
Net income	86,627		8,975
Less: Net income attributable to noncontrolling interests	(1,669)		(98)
Net income attributable to Acushnet Holdings Corp.	$	84,958	$	8,877
Net income per common share attributable to Acushnet Holdings Corp.:
Basic	$	1.14	$	0.12
Diluted	1.13		0.12
Weighted average number of common shares:
Basic	74,778,189		74,545,280
Diluted	75,255,312		75,099,930

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

ACUSHNET HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

	Three months ended March 31,
(in thousands)	2021		2020
Net income	$	86,627	$	8,975
Other comprehensive income (loss):
Foreign currency translation adjustments	(7,080)		(22,783)
Cash flow derivative instruments:
Unrealized holding gains arising during period	4,367		7,402
Reclassification adjustments included in net income	563		(1,724)
Tax expense	(1,664)		(1,848)
Cash flow derivative instruments, net	3,266		3,830
Pension and other postretirement benefits:
Pension and other postretirement benefits adjustments	2,575		1,690
Tax expense	(739)		(368)
Pension and other postretirement benefits adjustments, net	1,836		1,322
Total other comprehensive loss	(1,978)		(17,631)
Comprehensive income (loss)	84,649		(8,656)
Less: Comprehensive income attributable to noncontrolling interests	(1,529)		(118)
Comprehensive income (loss) attributable to Acushnet Holdings Corp.	$	83,120	$	(8,774)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

ACUSHNET HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	Three months ended March 31,
(in thousands)	2021		2020
Cash flows from operating activities
Net income	$	86,627	$	8,975
Adjustments to reconcile net income to cash flows used in operating activities
Depreciation and amortization	10,363		10,269
Unrealized foreign exchange gains	(3,593)		(200)
Amortization of debt issuance costs	917		213
Share-based compensation	5,533		2,187
Loss (gain) on disposals of property, plant and equipment	155		(2)
Deferred income taxes	10,265		(1,194)
Changes in operating assets and liabilities
Accounts receivable	(190,019)		(102,181)
Inventories	24,987		19,092
Accounts payable	13,788		(2,652)
Accrued taxes	15,039		(2,125)
Other assets and liabilities	(4,058)		(4,894)
Cash flows used in operating activities	(29,996)		(72,512)
Cash flows from investing activities
Additions to property, plant and equipment	(6,410)		(5,741)
Cash flows used in investing activities	(6,410)		(5,741)
Cash flows from financing activities
Proceeds from short-term borrowings, net	22,178		125,133
Repayments of term loan facility	(4,375)		(4,375)
Purchases of common stock	(2,377)		(6,976)
Debt issuance costs	—		(14)
Dividends paid on common stock	(12,658)		(11,521)
Dividends paid to noncontrolling interests	(48)		—
Payment of employee restricted stock tax withholdings	(3,946)		(380)
Cash flows (used in) provided by financing activities	(1,226)		101,867
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(773)		(1,874)
Net (decrease) increase in cash, cash equivalents and restricted cash	(38,405)		21,740
Cash, cash equivalents and restricted cash, beginning of year	151,452		34,184
Cash, cash equivalents and restricted cash, end of period	$	113,047	$	55,924
Supplemental information
Non-cash additions to property, plant and equipment	$	1,895	$	1,161
Non-cash additions to right-of-use assets obtained in exchange for operating lease obligations	1,291		2,020
Non-cash additions to right-of-use assets obtained in exchange for finance lease obligations	—		357
Dividend equivalents rights ("DERs") declared not paid	477		231
Share repurchase liability (Note 10)	2,347		6,976

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

9

ACUSHNET HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED)

	Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Loss, Net of Tax		Retained Earnings		Treasury Stock		Total Shareholders' Equity Attributable to Acushnet Holdings Corp.		Noncontrolling Interests		Total Shareholders' Equity
(in thousands)	Shares	Amount
Balances as of December 31, 2019	75,620	$	76	$	910,507	$	(112,028)	$	151,039	$	(31,154)	$	918,440	$	32,386	$	950,826
Net income	—	—		—		—		8,877		—		8,877		524		9,401
Other comprehensive loss	—	—		—		(17,631)		—		—		(17,631)		—		(17,631)
Share-based compensation	—	—		2,023		—		—		—		2,023		—		2,023
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	29	—		(368)		—		—		—		(368)		—		(368)
Purchases of common stock (Note 10)	—	—		—		—		—		(6,976)		(6,976)		—		(6,976)
Share repurchase liability (Note 10)	—	—		—		—		—		(6,976)		(6,976)		—		(6,976)
Dividends and dividend equivalents declared	—	—		—		—		(11,735)		—		(11,735)		—		(11,735)
Balances as of March 31, 2020	75,649	$	76	$	912,162	$	(129,659)	$	148,181	$	(45,106)	$	885,654	$	32,910	$	918,564
Balances as of December 31, 2020	75,666	$	76	$	925,385	$	(96,182)	$	199,776	$	(45,106)	$	983,949	$	33,304	$	1,017,253
Net income	—	—		—		—		84,958		—		84,958		1,862		86,820
Other comprehensive loss	—	—		—		(1,978)		—		—		(1,978)		—		(1,978)
Share-based compensation	—	—		5,369		—		—		—		5,369		—		5,369
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	181	—		(3,945)		—		—		—		(3,945)		—		(3,945)
Purchases of common stock (Note 10)	—	—		—		—		—		(2,377)		(2,377)		—		(2,377)
Share repurchase liability (Note 10)	—	—		—		—		—		(2,347)		(2,347)		—		(2,347)
Dividends and dividend equivalents declared	—	—		—		—		(12,767)		—		(12,767)		—		(12,767)
Dividends declared to noncontrolling interests	—	—		—		—		—		—		—		(48)		(48)
Balances as of March 31, 2021	75,847	$	76	$	926,809	$	(98,160)	$	271,967	$	(49,830)	$	1,050,862	$	35,118	$	1,085,980

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

10

ACUSHNET HOLDINGS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.

Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of results to be expected for the full year ending December 31, 2021, nor were those of the comparable 2020 period representative of those actually experienced for the full year ended December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2020 included in its Annual Report on Form 10-K filed with the SEC on February 25, 2021.

Risks and Uncertainties

In March 2020, the World Health Organization declared a pandemic related to the novel coronavirus (“COVID-19”), which led to government-ordered shutdowns of non-essential businesses, travel restrictions and restrictions on public gatherings. As a result of the government-ordered shutdowns, the Company was forced to temporarily close or substantially limit operations in its manufacturing facilities and distribution centers in the United States and Europe from mid-March 2020 through mid-May 2020, which disrupted business to varying degrees across many regions. The Company's manufacturing facilities and distribution centers reopened in mid-May 2020 and substantially all golf courses, on-course retail pro shops and off-course retail partner locations in the United States and Europe reopened by June 2020. The game of golf experienced a surge in rounds of play around the world primarily during the second half of 2020, in part due to its outdoor field of play and ease of social distancing, and rounds of play remained high through the first quarter of 2021.

While government-ordered shutdowns and restrictions have eased in most regions and mass vaccination programs are underway, it is nevertheless possible that a resurgence of positive cases could prompt a return to tighter restrictions in certain regions, as with the lockdown in the United Kingdom during the first quarter of 2021. While the Company has seen increased rounds of play and demand for golf and golf-related products, as mass vaccinations programs advance and restrictions are further eased on other activities, the increase in rounds of play and demand for golf-related products could decrease.

The Company has evaluated and continues to evaluate the potential impact of the COVID-19 pandemic on its consolidated financial statements. The impact of the COVID-19 pandemic continues to evolve, and both the full impact and duration of the COVID-19 pandemic remain highly uncertain. Accordingly, the Company's business, results of operations, financial position and cash flows could be materially impacted in ways that the Company cannot currently predict.

Use of Estimates

The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company has also made estimates related to the impact of the COVID-19 pandemic within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods. Actual results could differ from these estimates.

11

Variable Interest Entities

VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE.

The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2021 and December 31, 2020. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.

Noncontrolling Interests and Redeemable Noncontrolling Interest

The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The financial results and position of the noncontrolling interests are included in their entirety in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. The value attributable to the redeemable noncontrolling interest and the related loan to the minority shareholders, which is recorded as a reduction to redeemable noncontrolling interest, is presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders included in temporary equity on the unaudited condensed consolidated balance sheets was $4.4 million as of both March 31, 2021 and December 31, 2020. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.

Cash, Cash Equivalents and Restricted Cash

Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of both March 31, 2021 and December 31, 2020, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $2.0 million.

Foreign Currency Translation and Transactions

Foreign currency transaction losses included in selling, general and administrative expense were $1.0 million for each of the three months ended March 31, 2021 and 2020.

Recently Adopted Accounting Standards

Income Taxes

On January 1, 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). The amendments in this update simplified the accounting for income taxes by removing certain exceptions to general principles in Topic 740. The amendments also improved consistent application and simplified U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a material impact on the consolidated financial statements.

12

2. Accounts Receivable

The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions (including the impact of the COVID-19 pandemic) which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses.

The activity related to the allowance for doubtful accounts for the periods presented was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	7,698	$	5,338
Bad debt (recovery) expense	(445)		916
Amount of receivables written off	(144)		(286)
Foreign currency translation and other	(32)		(186)
Balance at end of period	$	7,077	$	5,782

3. Inventories

The components of inventories were as follows: 

	March 31,		December 31,
(in thousands)	2021		2020
Raw materials and supplies	$	73,080	$	74,302
Work-in-process	25,077		22,913
Finished goods	232,008		260,467
Inventories	$	330,165	$	357,682

4. Product Warranty

The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.

The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	3,831	$	4,048
Provision	1,029		1,209
Claims paid/costs incurred	(918)		(944)
Foreign currency translation and other	(43)		(164)
Balance at end of period	$	3,899	$	4,149

5. Debt and Financing Arrangements

Credit Facility

The credit facility includes a revolving credit facility and a term loan facility. There were outstanding borrowings under the revolving credit facility of $15.9 million as of March 31, 2021. The weighted average interest rate applicable to these outstanding borrowings was 1.79% as of March 31, 2021. There were no outstanding borrowings under the revolving credit facility as of December 31, 2020. As of March 31, 2021, the Company had available borrowings under its revolving credit facility of $376.0 million after giving effect to $8.1 million of outstanding letters of credit.

On July 3, 2020, the Company amended its credit agreement dated December 23, 2019 (the “First Amendment”) to, among other things, modify the maximum net average total leverage ratio, the interest rate margins, commitment fee and covenant baskets for each of the fiscal quarters ending after June 30, 2020 and on or before September 30, 2021 (the “Covenant

13

Relief Period”). On March 5, 2021, the Company issued a notice exercising its right to an early termination of the Covenant Relief Period and as such is now required to comply with the previous maximum net average total leverage ratio, and the interest rate margins, commitment fee and covenant baskets reverted to the levels in effect prior to the First Amendment as discussed below. In connection with terminating the Covenant Relief Period, the Company recorded additional interest expense of approximately $0.7 million related to the acceleration of unamortized debt issuance costs for the three months ended March 31, 2021.

Borrowings under the credit facility bear interest at a rate per annum equal to, at the applicable Borrower’s option, either (a) a base rate determined by reference to the highest of (1) the prime rate of Wells Fargo, (2) the federal funds effective rate plus 0.50% and (3) a Eurodollar Rate, subject to certain adjustments, plus 1.00% or (b) a Eurodollar Rate (or, in the case of Canadian borrowings, a Canadian Dollar Offered Rate), subject to certain adjustments, in each case, plus an applicable margin. Under the credit agreement, the applicable margin is 0% to 0.75% for base rate borrowings and 1.00% to 1.75% for Eurodollar rate or Canadian Dollar Offered Rate borrowings, in each case, depending on the Net Average Total Leverage Ratio (as defined in the credit agreement). In addition, the Company is required to pay a commitment fee on any unutilized commitments under the revolving credit facility. The commitment fee rate payable in respect of unused portions of the revolving credit facility is 0.15% to 0.30% per annum, depending on the Net Average Total Leverage Ratio. The initial commitment fee rate is 0.20% per annum. The maximum net average total leverage ratio under the credit facility is 3.50 to 1.00, which is subject to increase to 3.75 to 1.00 in connection with certain acquisitions, and the minimum consolidated interest coverage ratio (as defined in the credit agreement) is 3.00 to 1.00.

The credit agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2021, the Company was in compliance with all covenants under the credit agreement.

Other Short-Term Borrowings

The Company has certain unsecured local credit facilities available through its subsidiaries. There were outstanding borrowings under the Company's local credit facilities of $8.8 million and $2.8 million as of March 31, 2021 and December 31, 2020, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.28% and 2.00% as of March 31, 2021 and December 31, 2020, respectively. As of March 31, 2021, the Company had available borrowings remaining under these local credit facilities of $50.3 million.

Letters of Credit

As of March 31, 2021 and December 31, 2020, there were outstanding letters of credit related to agreements, including the Company's credit facility, totaling $11.8 million and $11.7 million, respectively, of which $8.6 million and $8.3 million, respectively, was secured. These agreements provided a maximum commitment for letters of credit of $53.7 million as of March 31, 2021.

6. Derivative Financial Instruments

The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.

14

Foreign Exchange Derivative Instruments

Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2021 and December 31, 2020 was $219.0 million and $248.1 million, respectively.

As a result of the impact of the COVID-19 pandemic, during the three months ended March 31, 2020, the Company de-designated certain foreign exchange cash flow hedges deemed ineffective, none of which were outstanding as of March 31, 2021 or December 31, 2020.

The Company also enters into foreign exchange forward contracts, which do not qualify as hedging instruments, to reduce foreign currency transaction risk related to certain intercompany assets and liabilities denominated in a currency other than functional currency. These undesignated instruments are recorded at fair value as a derivative asset or liability with the corresponding change in fair value recognized in selling, general and administrative expense. There were no outstanding foreign exchange forward contracts not designated under hedge accounting as of March 31, 2021 and December 31, 2020.

Interest Rate Derivative Instruments

The Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. The interest rate swap contracts are accounted for as cash flow hedges. As of March 31, 2021 and December 31, 2020, the notional value of the Company's outstanding interest rate swap contracts was $140.0 million.

Impact on Financial Statements

The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Hedge Instrument Type	2021		2020
Prepaid and other assets	Foreign exchange forward	$	3,476	$	1,166
Other assets	Foreign exchange forward	1,225		30
Accrued expenses and other liabilities	Foreign exchange forward	3,929		6,400
	Interest rate swap	621		1,571
Other noncurrent liabilities	Foreign exchange forward	92		985

The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Type of hedge
Foreign exchange forward	$	4,376	$	9,467
Interest rate swap	(9)		(2,065)
Total	$	4,367	$	7,402

Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net loss of $3.2 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold and a net loss of $0.6 million related to interest rate derivative instruments from accumulated other comprehensive loss, net of tax into interest expense, net. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.

15

The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Location of gain (loss) in statement of operations
Foreign exchange forward:
Cost of goods sold	$	396	$	1,542
Selling, general and administrative (1)(2)	640		1,534
Total	$	1,036	$	3,076
Interest Rate Swap:
Interest expense, net	$	(959)	$	(478)
Total	$	(959)	$	(478)

_______________________________________________________________________________

(1)    Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.

(2)    Selling, general and administrative expense for the three months ended March 31, 2020 excludes net gains of $0.7 million reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective.

Credit Risk

The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.

7. Fair Value Measurements

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

Assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 were as follows:

	Fair Value Measurements as of
	March 31, 2021 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,046	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		3,476		—		Prepaid and other assets
Deferred compensation program assets	803		—		—		Other assets
Foreign exchange derivative instruments	—		1,225		—		Other assets
Total assets	$	5,849	$	4,701	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	3,929	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		621		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	803		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		92		—		Other noncurrent liabilities
Total liabilities	$	803	$	4,642	$	—

16

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 were as follows:

	Fair Value Measurements as of
	December 31, 2020 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,160	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		1,166		—		Prepaid and other assets
Deferred compensation program assets	802		—		—		Other assets
Foreign exchange derivative instruments	—		30		—		Other assets
Total assets	$	5,962	$	1,196	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	6,400	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		1,571		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	802		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		985		—		Other noncurrent liabilities
Total liabilities	$	802	$	8,956	$	—

Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.

Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.

Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.

Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve.

8. Pension and Other Postretirement Benefits

Components of net periodic benefit cost (income) were as follows: 

	Pension Benefits				Postretirement Benefits
	Three months ended March 31,
(in thousands)	2021		2020		2021		2020
Components of net periodic benefit cost
Service cost	$	2,135	$	2,316	$	162	$	171
Interest cost	1,951		2,512		75		112
Expected return on plan assets	(2,547)		(2,903)		—		—
Settlement expense	1,419		—		—		—
Amortization of net loss (gain)	1,421		964		(65)		(214)
Amortization of prior service cost (credit)	71		70		(34)		(34)
Net periodic benefit cost	$	4,450	$	2,959	$	138	$	35

The non-service cost components of net periodic benefit cost (income) are included in other expense, net in the unaudited condensed consolidated statements of operations.

17

9. Income Taxes

Income tax expense increased by $20.2 million to $27.8 million for the three months ended March 31, 2021 compared to $7.6 million for the three months ended March 31, 2020. The Company’s effective tax rate ("ETR") was 24.3% for the three months ended March 31, 2021 compared to 46.0% for the three months ended March 31, 2020.

The ETR for the three months ended March 31, 2021 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income and the geographic mix of income earned by the Company's international subsidiaries, partially offset by the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits.

The ETR for the three months ended March 31, 2020 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income, the geographic mix of income earned by the Company's international subsidiaries and the effect of foreign currency losses that could not be benefited.

10. Common Stock

Dividends

The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:

	Dividends per Common Share		Amount (in thousands)
2021:
First Quarter	$	0.165	$	12,767
Total dividends declared in 2021	$	0.165	$	12,767
2020:
Fourth Quarter	$	0.155	$	11,983
Third Quarter	0.155		11,790
Second Quarter	0.155		11,761
First Quarter	0.155		11,735
Total dividends declared in 2020	$	0.620	$	47,269

During the second quarter of 2021, the Company's Board of Directors declared a dividend of $0.165 per share of common stock to shareholders of record as of June 4, 2021 and payable on June 18, 2021.

Share Repurchase Program

As of March 31, 2021, the Board of Directors had authorized the Company to repurchase up to an aggregate of $100.0 million of its issued and outstanding common stock. In April 2020, the Company temporarily suspended stock repurchases under its share repurchase program in light of the COVID-19 pandemic. In March 2021, the Company resumed share repurchases under its share repurchase program.

Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Company’s credit agreement. As previously disclosed, in connection with this share repurchase program, the Company entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly-owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of its common stock as it purchases on the open market, up to an aggregate of $24.9 million, at the same weighted average per share price.

The Company's share repurchase activity was as follows:

	Three months ended March 31,
(in thousands, except share and per share amounts)	2021		2020
Shares repurchased in the open market:
Shares repurchased	56,156		243,894
Average price	$	42.34	$	28.60
Aggregate value	$	2,377	$	6,976

18

In relation to the Magnus share repurchase agreement, the Company recorded a share repurchase liability of $11.1 million and $8.8 million for 355,341 and 299,894 shares of common stock to be repurchased from Magnus, which was included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020, respectively. Excluding the impact of the share repurchase liability, as of March 31, 2021, the Company had $61.3 million remaining under the current share repurchase authorization, including $11.1 million related to the Magnus share repurchase agreement.

As the Company repurchased a cumulative total of $24.9 million of common stock through open market purchases, the determination date, as defined in the Magnus share repurchase agreement, was automatically triggered on March 18, 2021. As a result, on April 2, 2021, the Company repurchased from Magnus 355,341 shares of common stock for an aggregate $11.1 million. At the completion of this transaction, the Company no longer had an obligation to repurchase shares of common stock from Magnus.

11. Equity Incentive Plans

Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (“2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the Board of Directors, officers, employees, consultants and advisors of the Company. As of March 31, 2021, the only awards granted under the 2015 Plan were RSUs and PSUs.

Restricted Stock and Performance Stock Units

RSUs granted to members of the Board of Directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally over three years, subject to the recipient’s continued service to the Company. PSUs vest, subject to the recipient's continued employment with the Company, based upon the Company's performance against specified metrics which are generally over a three year performance period. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these metrics. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.

All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.

A summary of the Company’s RSUs and PSUs as of March 31, 2021 and changes during the three months then ended is presented below: 

		Weighted-			Weighted-
	Number	Average		Number	Average
	of RSUs	Fair Value RSUs		of PSUs	Fair Value PSUs
Outstanding as of December 31, 2020	1,253,173	$	24.33	457,576	$	24.55
Granted	289,259	45.36		145,110	45.36
Vested (1)	(362,605)	24.11		—	—
Forfeited	(20,290)	24.24		(2,631)	25.45
Outstanding as of March 31, 2021	1,159,537	$	29.65	600,055	$	29.58

_______________________________________________________________________________

(1) Includes 110,514 shares of common stock related to RSUs and no shares of common stock related to PSUs that were not delivered as of March 31, 2021.

A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:

19

	Three months ended		Three months ended
	March 31, 2021		March 31, 2020
	RSUs	PSUs	RSUs	PSUs
Shares of common stock issued	270,779	—	42,797	—
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations	(89,938)	—	(13,831)	—
Net shares of common stock issued	180,841	—	28,966	—
Cumulative undelivered shares of common stock	395,670	—	240,512	—

Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
RSUs	$	2,359	$	2,478
PSUs	3,010		(455)

During the three months ended March 31, 2020, the Company adjusted the estimate of its performance against metrics for certain PSUs downward, resulting in a reversal of previously recognized share-based compensation expense. During both the second half of 2020 and the three months ended March 31, 2021, based on updated forecast information, the Company increased the estimate of its performance against metrics for these PSUs and recognized additional cumulative share-based compensation expense in both periods.

The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $23.4 million and $13.0 million, respectively, as of March 31, 2021 and is expected to be recognized over the related weighted average period of 2.3 years and 2.2 years, respectively.

Compensation Expense

The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Cost of goods sold	$	(7)	$	225
Selling, general and administrative	5,381		1,714
Research and development	159		248
Total compensation expense before income tax	5,533		2,187
Income tax benefit	1,267		463
Total compensation expense, net of income tax	$	4,266	$	1,724

20

12. Accumulated Other Comprehensive Loss, Net of Tax

Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).

The components of and changes in accumulated other comprehensive loss, net of tax, were as follows:

	Foreign		Gains (Losses) on		Gains (Losses) on		Pension and		Accumulated
	Currency		Foreign Exchange		Interest Rate		Other		Other
	Translation		Derivative		Swap Derivative		Postretirement		Comprehensive
(in thousands)	Adjustments		Instruments		Instruments		Adjustments		Loss, Net of Tax
Balance as of December 31, 2020	$	(43,906)	$	(4,471)	$	(1,179)	$	(46,626)	$	(96,182)
Other comprehensive income (loss) before reclassifications	(7,080)		4,376		(9)		(237)		(2,950)
Amounts reclassified from accumulated other comprehensive loss, net of tax	—		(396)		959		2,812		3,375
Tax expense	—		(1,435)		(229)		(739)		(2,403)
Balance as of March 31, 2021	$	(50,986)	$	(1,926)	$	(458)	$	(44,790)	$	(98,160)

13. Net Income per Common Share

The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:

	Three months ended
	March 31,
(in thousands, except share and per share amounts)	2021		2020
Net income attributable to Acushnet Holdings Corp.	$	84,958	$	8,877
Weighted average number of common shares:
Basic	74,778,189		74,545,280
Diluted	75,255,312		75,099,930
Net income per common share attributable to Acushnet Holdings Corp.:
Basic	$	1.14	$	0.12
Diluted	$	1.13	$	0.12

Net income per common share attributable to Acushnet Holdings Corp. for the three months ended March 31, 2021 and 2020 was calculated using the treasury stock method.

The Company’s potential dilutive securities for the three months ended March 31, 2021 and 2020 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement.

For the three months ended March 31, 2021 and 2020, the following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:

	Three months ended
	March 31,
	2021	2020
RSUs	291,484	—

21

14. Segment Information

The Company’s operating segments are based on how the Chief Operating Decision Maker (“CODM”) makes decisions about assessing performance and allocating resources. The Company has four reportable segments that are organized on the basis of product categories. These segments include Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear.

The CODM primarily evaluates performance using segment operating income (loss). Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes interest expense, net, restructuring charges, the non-service cost component of net periodic benefit cost, transaction fees and other non-operating gains and losses as the Company does not allocate these to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance.

Results shown for the three months ended March 31, 2021 and 2020 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions.

Information by reportable segment and a reconciliation to reported amounts are as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Net sales
Titleist golf balls	$	173,637	$	116,239
Titleist golf clubs	155,827		93,214
Titleist golf gear	53,120		43,525
FootJoy golf wear	159,434		130,387
Other	38,867		25,376
Total net sales	$	580,885	$	408,741
Segment operating income
Titleist golf balls	$	34,317	$	3,243
Titleist golf clubs	41,799		4,503
Titleist golf gear	9,728		8,865
FootJoy golf wear	28,117		14,297
Other	6,471		1,080
Total segment operating income	120,432		31,988
Reconciling items:
Interest expense, net	(3,616)		(4,123)
Restructuring charges	—		(11,628)
Non-service cost component of net periodic benefit cost	(2,291)		(507)
Other	(64)		885
Total income before income tax	$	114,461	$	16,615

Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.

	Three months ended March 31,
(in thousands)	2021		2020
United States	$	308,636	$	211,008
EMEA (1)	80,575		74,671
Japan	56,377		37,556
Korea	79,097		50,449
Rest of world	56,200		35,057
Total net sales	$	580,885	$	408,741

_______________________________________________________________________________

(1) Europe, the Middle East and Africa ("EMEA")

22

15. Commitments and Contingencies

Purchase Obligations

During the normal course of its business, the Company enters into agreements to purchase goods and services, including purchase commitments for production materials, finished goods inventory, capital expenditures and endorsement arrangements with professional golfers.

The Company's purchase obligations as of March 31, 2021 were as follows:

	Payments Due by Period
	Remainder of
(in thousands)	2021		2022		2023		2024		2025		Thereafter
Purchase obligations (1)	$	200,097	$	16,026	$	3,282	$	2,545	$	2,549	$	1,284

_______________________________________________________________________________

(1)    The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2021.

Litigation

The Company and its subsidiaries are defendants in lawsuits associated with the normal conduct of their businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably. Consequently, the Company is unable to estimate the ultimate aggregate amount of monetary loss, amounts covered by insurance or the financial impact that will result from such matters and has not recorded a liability related to potential losses.

16. Restructuring Charges

During the first quarter of 2020, management approved a restructuring program to refine its business model and improve operational efficiencies. This program included both a voluntary bridge to retirement ("VBR") program for certain eligible employees and involuntary headcount reductions ("Other"). The VBR program was part of the Company's long-term strategic planning process and was designed to bridge eligible employees to retirement. As part of this program, employees were offered severance in the form of salary continuation, including benefits, as well as accrued bonus incentives. Costs associated with the involuntary headcount reductions include severance and other benefits related to these headcount reductions. The Company recorded cumulative severance and other benefits expense of $11.2 million related to its VBR program and $2.0 million related to its Other restructuring program, of which $11.2 million and $0.4 million was recorded during the three months ended March 31, 2020 related to the VBR program and Other program, respectively. There are no further costs expected to be incurred in relation to these programs.

The activity related to the Company’s restructuring programs was as follows:

	Three months ended March 31, 2021
(in thousands)	VBR		Other
Balance at beginning of period	$	6,243	$	778
Payments	(2,161)		(565)
Foreign currency translation and other	—		(1)
Balance at end of period	$	4,082	$	212

The restructuring program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Restructuring Program	2021		2020
Accrued compensation and benefits	VBR	$	4,039	$	6,018
	Other	212		778
Other noncurrent liabilities	VBR	43		225

23

ITEM 2.      MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion contains management’s discussion and analysis of our financial condition and results of operations and should be read together with our unaudited condensed consolidated financial statements and the notes thereto included elsewhere in this report. This discussion contains forward-looking statements that reflect our plans, estimates and beliefs and involve numerous risks and uncertainties, including those described in “Part II, Item 1A. Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (“SEC”). Actual results may differ materially from those contained in any forward-looking statements. You should carefully read “Special Note Regarding Forward-Looking Statements” following the Table of Contents. Unless otherwise noted, the figures in the following discussion are unaudited.

Overview

We are the global leader in the design, development, manufacture and distribution of performance-driven golf products, which are widely recognized for their quality excellence. Today, we are the steward of two of the most revered brands in golf—Titleist, one of golf’s leading performance equipment brands, and FootJoy, one of golf’s leading performance wear brands.

Our target market is dedicated golfers, who are the cornerstone of the worldwide golf industry. These dedicated golfers are avid and skill-biased, prioritize performance and commit the time, effort and money to improve their game. We believe our focus on innovation and process excellence yields golf products that represent superior performance and consistent product quality, which are the key attributes sought after by dedicated golfers. Many of the game's professional players, who represent the most dedicated golfers, prefer our products, thereby validating our performance and quality promise, while also driving brand awareness. We seek to leverage a pyramid of influence product and promotion strategy, whereby our products are the most played by the best players, creating aspirational appeal for a broad range of golfers who want to emulate the performance of the game's best players.

Our net sales are diversified by both product category and mix as well as geography. Our product categories include golf balls, golf clubs, wedges and putters, golf shoes, golf gloves, golf gear and golf outerwear and apparel. Our product portfolio contains a favorable mix of consumable products, which we consider to be golf balls and golf gloves, and more durable products, which we consider to be golf clubs, golf shoes, golf gear and golf outerwear and apparel. Our net sales are also diversified by geography with a substantial majority of our net sales generated in five countries: the United States, Japan, Korea, the United Kingdom and Canada. We have the following reportable segments: Titleist golf balls; Titleist golf clubs; Titleist golf gear; and FootJoy golf wear.

Impact of COVID-19 on our Business

In March 2020, the World Health Organization declared a pandemic related to the novel coronavirus (“COVID-19”), which led to government-ordered shutdowns of non-essential businesses, travel restrictions and restrictions on public gatherings. As a result of the government-ordered shutdowns we were forced to temporarily close or substantially limit our operations in our manufacturing facilities and distribution centers in the United States and Europe from the mid-March 2020 through mid-May 2020 which disrupted our business to varying degrees across many regions. As a result, the COVID-19 pandemic materially impacted our results of operations for the first half of 2020.

Our manufacturing facilities and distribution centers reopened in mid-May 2020 and substantially all golf courses, on-course retail pro shops and off-course retail partner locations in the United States and Europe reopened by June 2020. The game of golf experienced a surge in rounds of play around the world, in part due to its outdoor field of play and ease of social distancing. Dedicated golfers found opportunities to play even more and recreational or lapsed golfers returned to the game as a healthy diversion. This surge resulted in increased demand for our products during June 2020 and even greater demand for our products during the second half of 2020 in the United States and Europe. On a Company-wide basis, we quickly began to experience demand pressures across all brands and product categories, which challenged, and continue to challenge, our supply chain and our ability to service our trade partners and golfers.

During the first quarter of 2021, rounds of play remained high and we continued to see an increase in demand for our products, leading to increased sales volumes across all segments. However, during this period, we also experienced supply chain disruptions causing shortages of various raw materials and increased freight charges.

While government-ordered shutdowns and restrictions have eased in most regions and mass vaccination programs are underway, it is nevertheless possible that a resurgence of positive cases could prompt a return to tighter restrictions in certain

24

regions, as we saw with the lockdown in the United Kingdom during the first quarter of 2021. While we have seen increased rounds of play and demand for golf and golf-related products, as mass vaccinations programs advance and restrictions are further eased on other activities, the increase in rounds of play and demand for golf-related products could decrease. Accordingly, our business, results of operations, financial position and cash flows could be materially impacted in ways that we cannot currently predict.

Key Performance Measures

We use various financial metrics to measure and evaluate our business, including, among others: (i) net sales on a constant currency basis, (ii) Adjusted EBITDA on a consolidated basis, (iii) Adjusted EBITDA margin on a consolidated basis and (iv) segment operating income.

Since a significant percentage of our net sales are generated outside of the United States, we use net sales on a constant currency basis to evaluate the sales performance of our business in period over period comparisons and for forecasting our business going forward. Constant currency information allows us to estimate what our sales performance would have been without changes in foreign currency exchange rates. This information is calculated by taking the current period local currency sales and translating them into U.S. dollars based upon the foreign currency exchange rates for the applicable comparable prior period. This constant currency information should not be considered in isolation or as a substitute for any measure derived in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Our presentation of constant currency information may not be consistent with the manner in which similar measures are derived or used by other companies.

We primarily use Adjusted EBITDA on a consolidated basis to evaluate the effectiveness of our business strategies, assess our consolidated operating performance and make decisions regarding pricing of our products, go to market execution and costs to incur across our business. We present Adjusted EBITDA as a supplemental measure of our operating performance because it excludes the impact of certain items that we do not consider indicative of our ongoing operating performance. We define Adjusted EBITDA in a manner consistent with the term “Consolidated EBITDA” as it is defined in our credit agreement. Adjusted EBITDA represents net income (loss) attributable to Acushnet Holdings Corp. plus interest expense, net, income tax expense (benefit), depreciation and amortization and other items defined in the agreement, including: share-based compensation expense; restructuring and transformation costs; certain transaction fees; extraordinary, unusual or non-recurring losses or charges; indemnification expense (income); certain pension settlement costs; certain other non-cash (gains) losses, net and the net income relating to noncontrolling interests. Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP. It should not be considered an alternative to net income (loss) attributable to Acushnet Holdings Corp. as a measure of our operating performance or any other measure of performance derived in accordance with U.S. GAAP. In addition, Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, or affected by similar non-recurring items. Adjusted EBITDA has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Our definition and calculation of Adjusted EBITDA is not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation. For a reconciliation of Adjusted EBITDA to net income (loss) attributable to Acushnet Holdings Corp., see “—Results of Operations” below.

We also use Adjusted EBITDA margin on a consolidated basis, which measures our Adjusted EBITDA as a percentage of net sales, because our management uses it to evaluate the effectiveness of our business strategies, assess our consolidated operating performance and make decisions regarding pricing of our products, go to market execution and costs to incur across our business. We present Adjusted EBITDA margin as a supplemental measure of our operating performance because it excludes the impact of certain items that we do not consider indicative of our ongoing operating performance. Adjusted EBITDA margin is not a measurement of financial performance under U.S. GAAP. It should not be considered an alternative to any measure of performance derived in accordance with U.S. GAAP. In addition, Adjusted EBITDA margin should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, or affected by similar non-recurring items. Adjusted EBITDA margin has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Our definition and calculation of Adjusted EBITDA margin is not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation.

Lastly, we use segment operating income to evaluate and assess the performance of each of our reportable segments and to make budgeting decisions. Segment operating income includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes interest expense, net; restructuring charges; the non-service cost component of net periodic benefit cost; transaction fees and other non-operating gains and losses as we do not allocate these to the reportable segments.

25

Results of Operations

The following table sets forth, for the periods indicated, our results of operations.

	Three months ended
	March 31,
(in thousands)	2021			2020
Net sales	$	580,885		$	408,741
Cost of goods sold	270,146			207,786
Gross profit	310,739			200,955
Operating expenses:
Selling, general and administrative	176,369			152,723
Research and development	12,329			13,220
Intangible amortization	1,972			1,956
Restructuring charges	—			11,628
Income from operations	120,069			21,428
Interest expense, net	3,616			4,123
Other expense, net	1,992			690
Income before income taxes	114,461			16,615
Income tax expense	27,834			7,640
Net income	86,627			8,975
Less: Net income attributable to noncontrolling interests	(1,669)			(98)
Net income attributable to Acushnet Holdings Corp.	$	84,958		$	8,877
Adjusted EBITDA:
Net income attributable to Acushnet Holdings Corp.	$	84,958		$	8,877
Interest expense, net	3,616			4,123
Income tax expense	27,834			7,640
Depreciation and amortization	10,363			10,269
Share-based compensation	5,533			2,187
Restructuring & transformation costs (1)	—			11,628
Other extraordinary, unusual or non-recurring items, net (2)	1,311			7,986
Net income attributable to noncontrolling interests	1,669			98
Adjusted EBITDA	$	135,284		$	52,808
Adjusted EBITDA margin	23.3		%	12.9		%

_______________________________________________________________________________________

(1)Relates to severance and other costs associated with management's approved restructuring program to refine the Company's business model and improve operational efficiencies.

(2)The three months ended March 31, 2021 includes pension settlement costs of $1.4 million related to lump-sum distributions to participants in our defined benefit plans as a result of the voluntary retirement program as part of management’s approved restructuring program. The three months ended March 31, 2020 includes salaries and benefits paid for associates who could not work due to government mandated shutdowns, fringe benefits paid for furloughed associates, spoiled raw materials, incremental costs to support remote work and the cost of additional health and safety equipment of $7.5 million. Also includes other immaterial unusual or non-recurring items, net for the three months ended March 31, 2021 and 2020.

26

Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31, 2020

Net sales by reportable segment is summarized as follows: 

	Three months ended								Constant Currency
	March 31,				Increase/(Decrease)				Increase/(Decrease)
(in millions)	2021		2020		$ change		% change		$ change		% change
Titleist golf balls	$	173.6	$	116.2	$	57.4	49.4	%	$	53.1	45.7	%
Titleist golf clubs	155.8		93.2		62.6		67.2	%	58.7		63.0	%
Titleist golf gear	53.1		43.5		9.6		22.1	%	7.6		17.5	%
FootJoy golf wear	159.4		130.4		29.0		22.2	%	23.5		18.0	%

Net sales information by region is summarized as follows: 

	Three months ended								Constant Currency
	March 31,				Increase/(Decrease)				Increase/(Decrease)
(in millions)	2021		2020		$ change		% change		$ change		% change
United States	$	308.6	$	211.0	$	97.6	46.3	%	$	97.6	46.3	%
EMEA	80.6		74.7		5.9		7.9	%	(0.8)		(1.1)	%
Japan	56.4		37.6		18.8		50.0	%	17.4		46.3	%
Korea	79.1		50.4		28.7		56.9	%	23.5		46.6	%
Rest of world	56.2		35.0		21.2		60.6	%	16.7		47.7	%
Total net sales	$	580.9	$	408.7	$	172.2	42.1	%	$	154.4	37.8	%

Segment operating income by reportable segment is summarized as follows: 

	Three months ended
(in millions)	March 31,				Increase/(Decrease)
Segment operating income	2021		2020		$ change		% change
Titleist golf balls	$	34.3	$	3.2	$	31.1	*
Titleist golf clubs	41.8		4.5		37.3		*
Titleist golf gear	9.7		8.9		0.8		9.0	%
FootJoy golf wear	28.1		14.3		13.8		96.5	%

_______________________________________________________________________________

*Percentage change not meaningful

Net Sales

Net sales increased by $172.2 million, or 42.1%, to $580.9 million for the three months ended March 31, 2021 compared to $408.7 million for the three months ended March 31, 2020. On a constant currency basis, net sales increased by $154.4 million, or 37.8%, to $563.1 million. The increase in net sales on a constant currency basis was due to sales volume increases across all reportable segments, as rounds of play and consumer demand for golf-related products remained at a high level during the first quarter of 2021. In addition, as discussed above, the first quarter of 2020 was unfavorably impacted by government-ordered shutdowns. Sales volume growth of products that are not allocated to one of our four reportable segments also contributed to the increase in net sales.

The increase in net sales in the United States was primarily driven by an increase of $41.7 million in Titleist golf balls, an increase of $37.2 million in Titleist golf clubs, an increase of $13.4 million in FootJoy golf wear and an increase of $5.2 million in Titleist golf gear, all driven by the same factors discussed above.

Net sales in regions outside of the United States increased by $74.6 million, or 37.7%, to $272.3 million for the three months ended March 31, 2021 compared to $197.7 million for the three months ended March 31, 2020. On a constant currency basis, net sales in such regions increased by $56.8 million, or 28.7%, to $254.5 million. In Korea, Japan and Rest of world, the increase in net sales was primarily driven by increased sales across all reportable segments. In EMEA, the decrease in net sales primarily resulted from the government-ordered shutdowns in this region during the first quarter of 2021 as discussed above.

27

Gross Profit

Gross profit increased by $109.7 million to $310.7 million for the three months ended March 31, 2021 compared to $201.0 million for the three months ended March 31, 2020. Gross margin increased to 53.5% for the three months ended March 31, 2021 compared to 49.2% for the three months ended March 31, 2020. The increase in gross profit primarily resulted from an increase of $41.0 million in Titleist golf clubs, an increase of $35.4 million in Titleist golf balls, an increase of $20.1 million in FootJoy golf wear and an increase of $4.9 million in Titleist golf gear, each primarily due to the sales volume increases discussed above, partially offset by increased inbound freight costs.

The increase in gross margin was primarily driven by higher gross margins in Titleist golf clubs, Titleist golf balls and FootJoy golf wear. The increase in Titleist golf clubs was primarily driven by a favorable product mix shift and higher average selling prices. The increase in the Titleist golf ball segment was primarily driven by favorable manufacturing overhead absorption primarily driven by sales volume increases and a favorable product mix shift. The increase in FootJoy golf wear was primarily driven by a higher percentage of global eCommerce sales and retail sales in Korea. Increased inbound freight costs partially offset the gross margin increases across all reportable segments.

Selling, General and Administrative Expenses

SG&A expenses increased by $23.7 million to $176.4 million for the three months ended March 31, 2021 compared to $152.7 million for the three months ended March 31, 2020. This increase primarily resulted from an increase of $17.8 million in selling expense primarily due to higher sales volumes described above and an increase of $7.2 million in administrative expense primarily due to employee related expenses, partially offset by a decrease of $2.7 million in advertising and promotional expenses. Overall, SG&A included a $3.8 million unfavorable impact of changes in foreign currency exchange rates across all expense categories and segments.

Restructuring Charges

During the three months ended March 31, 2020, we recorded $11.2 million in severance and other benefits expense related to our voluntary retirement program, as well as $0.4 million in severance and other benefits related to involuntary headcount reductions both associated with our restructuring program approved in the first quarter of 2020. There were no additional charges related to these programs recorded during the three months ended March 31, 2021.

Other Expense, net

Other expense, net increased by $1.3 million to $2.0 million for the three months ended March 31, 2021 compared to $0.7 million for the three months ended March 31, 2020. This increase was primarily due to pension settlement costs of $1.4 million recorded during the three months ended March 31, 2021 related to lump-sum distributions to participants in our defined benefit plans as a result of the voluntary retirement program associated with management’s approved restructuring program.

Income Tax Expense

Income tax expense increased by $20.2 million to $27.8 million for the three months ended March 31, 2021 compared to $7.6 million for the three months ended March 31, 2020. Our effective tax rate ("ETR") was 24.3% for the three months ended March 31, 2021 compared to 46.0% for the three months ended March 31, 2020. The change in the ETR was primarily driven by the impact of the COVID-19 pandemic on our jurisdictional mix of earnings.

Segment Results

Titleist Golf Balls Segment

Net sales in our Titleist golf balls segment increased by $57.4 million, or 49.4%, to $173.6 million for the three months ended March 31, 2021 compared to $116.2 million for the three months ended March 31, 2020. On a constant currency basis, net sales in our Titleist golf balls segment increased by $53.1 million, or 45.7%, to $169.3 million. This increase was primarily driven by higher sales volumes of our latest generation Pro V1 and Pro V1x golf balls launched in the first quarter of 2021.

Operating income in our Titleist golf balls segment increased by $31.1 million to $34.3 million for the three months ended March 31, 2021 compared to $3.2 million for the three months ended March 31, 2020. The increase in operating income resulted from higher gross profit of $35.4 million, partially offset by higher operating expenses. The increase in gross profit was primarily driven by the sales volume increase discussed above and favorable manufacturing overhead absorption primarily driven by higher production volumes, partially offset by increased inbound freight costs. Operating expenses increased

28

primarily as a result of increases of $2.9 million and $2.5 million in administrative and selling expenses, respectively, as discussed above.

Titleist Golf Clubs Segment

Net sales in our Titleist golf clubs segment increased by $62.6 million, or 67.2%, to $155.8 million for the three months ended March 31, 2021 compared to $93.2 million for the three months ended March 31, 2020. On a constant currency basis, net sales in our Titleist golf clubs segment increased by $58.7 million, or 63.0%, to $151.9 million. This increase was primarily driven by higher sales volumes of our TSi drivers and TSi fairways launched in the fourth quarter of 2020, our TSi hybrids and Phantom X putters each launched in the first quarter of 2021 and higher average selling prices across all categories, partially offset by lower sales volumes of our previous generation wedges.

Operating income in our Titleist golf clubs segment increased by $37.3 million to $41.8 million for the three months ended March 31, 2021 compared to $4.5 million for the three months ended March 31, 2020. The increase in operating income resulted from higher gross profit of $41.0 million driven by the sales volume increase discussed above and higher average selling prices, partially offset by increased inbound freight costs and higher operating expenses. Higher operating expenses were primarily as a result of increases of $2.3 million and $2.1 million in selling and administrative expenses, respectively, as discussed above.

Titleist Golf Gear Segment

Net sales in our Titleist golf gear segment increased by $9.6 million, or 22.1%, to $53.1 million for the three months ended March 31, 2021 compared to $43.5 million for the three months ended March 31, 2020. On a constant currency basis, net sales in our Titleist golf gear segment increased by $7.6 million, or 17.5%, to $51.1 million. This increase was due to sales volume increases across all categories of the gear business.

Operating income in our Titleist golf gear segment increased by $0.8 million, or 9.0%, to $9.7 million for the three months ended March 31, 2021 compared to $8.9 million for the three months ended March 31, 2020. The increase in operating income resulted from higher gross profit of $4.9 million driven by the sales volume increase discussed above, partially offset by increased inbound freight costs and higher operating expenses. Operating expenses increased primarily as a result of an increase of $2.8 million in selling expense, as discussed above.

FootJoy Golf Wear Segment

Net sales in our FootJoy golf wear segment increased by $29.0 million, or 22.2%, to $159.4 million for the three months ended March 31, 2021 compared to $130.4 million for the three months ended March 31, 2020. On a constant currency basis, net sales in our FootJoy golf wear segment increased by $23.5 million, or 18.0%, to $153.9 million. This increase was driven by sales volume increases in footwear and golf gloves and higher average selling prices across all product categories.

Operating income in our FootJoy golf wear segment increased by $13.8 million, or 96.5%, to $28.1 million for the three months ended March 31, 2021 compared to $14.3 million for the three months ended March 31, 2020. The increase in operating income resulted from higher gross profit of $20.1 million as a result of the sales volume increase discussed above, a higher percentage of global eCommerce sales and retail sales in Korea, partially offset by increased inbound freight costs and higher operating expenses. Operating expenses increased primarily as a result of increases of $6.6 million and $1.4 million in selling and administrative expenses, respectively, as discussed above, partially offset by a decrease of $1.5 million in advertising and promotion expenses.

29

Liquidity and Capital Resources

Our primary cash needs relate to working capital, capital expenditures, servicing of our debt, paying dividends, pension contributions and repurchasing shares of our common stock. We expect to rely on cash flows from operations and borrowings under our revolving credit facility and local credit facilities as our primary sources of liquidity.

Our liquidity is impacted by our level of working capital, which is cyclical as a result of the general seasonality of our business. Our accounts receivable balance is generally at its highest starting at the end of the first quarter and continuing through the second quarter, and declines during the third and fourth quarters as a result of both an increase in cash collections and lower sales. Our inventory balance also fluctuates as a result of the seasonality of our business. Generally, our buildup of inventory starts during the fourth quarter and continues through the first quarter and into the beginning of the second quarter in order to meet demand for our initial sell-in during the first quarter and reorders in the second quarter. Both accounts receivable and inventory balances are impacted by the timing of new product launches.

As of March 31, 2021, we had $111.1 million of unrestricted cash and cash equivalents (including $7.9 million attributable to our FootJoy golf shoe variable interest entity). As of March 31, 2021, 56.5% of our total unrestricted cash and cash equivalents was held at our non-U.S. subsidiaries. We manage our worldwide cash requirements by monitoring the funds available among our subsidiaries and determining the extent to which we can access those funds on a cost effective basis. We are not aware of any restrictions on repatriation of these funds and, subject to foreign withholding taxes, those funds could be repatriated, if necessary. We have repatriated, and intend to repatriate, funds to the United States from time to time to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs related to debt service requirements.

As noted previously, the COVID-19 pandemic could impact our results of operations in ways we cannot currently predict. Subject to the length and severity of the COVID-19 pandemic, we believe that cash expected to be provided by operating activities, together with our cash on hand and the availability of borrowings under our revolving credit facility and our local credit facilities (subject to customary borrowing conditions) will be sufficient to meet our liquidity requirements for at least the next 12 months. Our ability to generate sufficient cash flows from operations is, however, subject to many risks and uncertainties, including future economic trends and conditions, including the current COVID-19 pandemic, demand for our products, foreign currency exchange rates and other risks and uncertainties applicable to our business, as described in our Annual Report on Form 10-K for the year ended December 31, 2020.

Debt and Financing Arrangement

As of March 31, 2021, we had $376.0 million of availability under our revolving credit facility after giving effect to $8.1 million of outstanding letters of credit. Additionally, we had $50.3 million available under our local credit facilities.

Our credit agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on our leverage and interest coverage ratios. On March 5, 2021, we issued a notice exercising our right to an early termination of the covenant relief period under our amended credit agreement and as such are required to comply with the previous maximum net average total leverage ratio, and the interest rate margins, commitment fee and covenant baskets in effect prior to the amendment. See “Notes to Consolidated Financial Statements-Note-5-Debt and Financing Arrangements,” Item 1 of Part I included elsewhere in this report for a description of our credit agreement. The credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2021, we were in compliance with all covenants under the credit agreement.

See “Notes to Consolidated Financial Statements-Note-10-Debt and Financing Arrangements” in our Annual Report on Form 10-K for the year ended December 31, 2020 for a further description of our credit facilities. Additionally, see "Risk Factors - Risks Related to Our Indebtedness" as described in our Annual Report on Form 10-K for the year ended December 31, 2020.

Capital Expenditures

We made $6.4 million of capital expenditures during the three months ended March 31, 2021. Capital expenditures for the full year are expected to be in the range of $45 to $50 million, although the actual amount may vary depending upon a variety of factors, including the timing of implementation of certain capital projects. Capital expenditures generally relate to investments to support the manufacturing and distribution of products, our go-to-market activities and continued investments in information technology to support our global strategic initiatives. The increase in projected capital expenditures in 2021 is primarily related to key strategic investments in our golf ball operations and precision manufacturing capabilities.

30

Dividends and Share Repurchase Program

The Board of Directors has authorized us to repurchase up to an aggregate of $100.0 million of our issued and outstanding common stock. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at our discretion consistent with our general working capital needs and within the constraints of our credit agreement. This program will remain in effect until completed or until terminated by the Board of Directors. In connection with this share repurchase program, we entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of our common stock as we purchase on the open market, up to an aggregate of $24.9 million, at the same weighted average per share price.

In March of 2021, we resumed share repurchases under our share repurchase program. During the three months ended March 31, 2021, we repurchased 56,156 shares of common stock on the open market at an average price of $42.34 for an aggregate of $2.4 million. As a result of these purchases, we recorded an additional liability to repurchase additional shares of common stock from Magnus of $2.3 million (55,447 shares of common stock) bringing the total liability to $11.1 million (355,341 shares of common stock) as of March 31, 2021. Excluding the impact of the share repurchase liability, as of March 31, 2021, we had $61.3 million remaining under the current share repurchase program, including $11.1 million related to the Magnus share repurchase agreement. In relation to the Magnus share repurchase agreement, on April 2, 2021, the Company repurchased from Magnus 355,341 shares of common stock for an aggregate of $11.1 million. See “Notes to Consolidated Financial Statements-Note-10-Common Stock,” Item 1 of Part I included elsewhere in this report for a description of our Magnus share repurchase agreement.

During the three months ended March 31, 2021, we paid dividends on our common stock of $12.7 million to our shareholders. During the second quarter of 2021, our Board of Directors declared a dividend of $0.165 per share of common stock to shareholders of record as of June 4, 2021 and payable on June 18, 2021.

Cash Flows

The following table presents the major components of net cash flows provided by (used in) operating, investing and financing activities for the periods indicated:

	Three months ended
	March 31,
(in thousands)	2021		2020
Cash flows provided by (used in):
Operating activities	$	(29,996)	$	(72,512)
Investing activities	(6,410)		(5,741)
Financing activities	(1,226)		101,867
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(773)		(1,874)
Net (decrease) increase in cash, cash equivalents and restricted cash	$	(38,405)	$	21,740

Cash Flows from Operating Activities

Net cash used in operating activities was $30.0 million for the three months ended March 31, 2021 compared to $72.5 million for the three months ended March 31, 2020, a decrease in cash used in operating activities of $42.5 million. The decrease in cash used in operating activities was primarily driven by an increase in net income offset in part by changes in working capital, both as a result of a significant increase in rounds of play and related consumer demand for golf-related products. Working capital at any specific point in time is subject to many variables including seasonality and inventory management, the timing of cash receipts and payments, vendor payment terms, and fluctuations in foreign exchange rates.

Cash Flows from Investing Activities    

Net cash used in investing activities was $6.4 million for the three months ended March 31, 2021 compared to $5.7 million for the three months ended March 31, 2020, an increase in cash used in investing activities of $0.7 million driven by changes in capital expenditures.

31

Cash Flows from Financing Activities

Net cash used in financing activities was $1.2 million for the three months ended March 31, 2021 compared to net cash provided by financing activities of $101.9 million for the three months ended March 31, 2020, an increase in cash used in financing activities of $103.1 million. This increase was primarily due to a decrease in net proceeds from borrowings.

Off-Balance Sheet Arrangements

As of March 31, 2021, other than as discussed above, we did not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates from the information provided in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our Annual Report on Form 10-K for the year ended December 31, 2020.

Recently Issued Accounting Standards

See Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this report for recently issued accounting standards, if any, including the dates of adoption and estimated effects on our consolidated financial statements.

32

ITEM 3.      Quantitative and Qualitative Disclosures About Market Risk

We are exposed to various market risks, which may result in potential losses arising from adverse changes in market rates, such as interest rates, foreign exchange rates and commodity prices, as well as inflation risk. We do not enter into derivatives or other financial instruments for trading or speculative purposes and do not believe we are exposed to material market risk with respect to our cash and cash equivalents.

COVID-19 Pandemic

Uncertainty with respect to the economic impact of the COVID-19 pandemic has introduced significant volatility in the financial markets and has impacted interest rates, foreign exchange rates and commodity prices. The COVID-19 pandemic continues to be fluid and uncertain, making it difficult to forecast the ultimate impact it could have on our future operations.

Interest Rate Risk

We are exposed to interest rate risk under our various credit facilities, which accrue interest at variable rates. Interest rate risk is highly sensitive due to many factors, including U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. We are exposed to changes in the level of interest rates and to changes in the relationship or spread between interest rates for our floating rate debt. Our floating rate debt requires payments based on a variable interest rate index such as LIBOR. The LIBOR rate, on which the Eurodollar Rate is based, is expected to be discontinued by the end of 2021. The credit agreement permits us to agree with the administrative agent for the credit facility on a replacement benchmark rate subject to certain conditions (including that a majority of the lenders do not object to such replacement rate within a specified period of time following notice thereof from the administrative agent). Increases in interest rates may reduce our net income by increasing the cost of our debt.

During 2018, we entered into interest rate swap contracts to reduce our interest rate risk. Under these contracts, we pay fixed and receive variable rate interest, in effect converting a portion of our floating rate debt to fixed rate debt. As of March 31, 2021, the notional value of our outstanding interest rate swap contracts was $140.0 million. See "Notes to Unaudited Condensed Consolidated Financial Statement-Note-6-Derivative Financial Instruments" for further discussion of our interest rate swap contracts.

We performed a sensitivity analysis to assess the potential effect of a hypothetical movement in interest rates on our pre-tax interest expense. As of March 31, 2021, we had $212.8 million of outstanding indebtedness at variable interest rates (excluding unamortized debt issuance costs) after giving effect to $140.0 million of hedged floating rate indebtedness. The sensitivity analysis, while not predictive in nature, indicated that a one percentage point increase in the interest rate applied to these borrowings as of March 31, 2021 would have resulted in an increase of $2.1 million in our annual pre-tax interest expense.

Foreign Exchange Risk

We are exposed to foreign currency transaction risk related to transactions denominated in a currency other than functional currency. In addition, we are exposed to currency translation risk resulting from the translation of the financial results of our consolidated subsidiaries from their functional currency into U.S. dollars for financial reporting purposes.

We use financial instruments to reduce the earnings and shareholders' equity volatility relating to transaction risk. The principal financial instruments we enter into on a routine basis are foreign exchange forward contracts, primarily pertaining to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The periods of the foreign exchange forward contracts designated as hedges correspond to the periods of the forecasted hedged transactions, which do not exceed 24 months subsequent to the latest balance sheet date. See "Notes to Unaudited Condensed Consolidated Financial Statements-Note-6-Derivative Financial Instruments" for further discussion of our foreign currency derivative instruments.

We performed a sensitivity analysis to assess potential changes in the fair value of our foreign exchange forward contracts relating to a hypothetical movement in foreign currency exchange rates. The gross U.S. dollar equivalent notional amount of all foreign exchange forward contracts outstanding at March 31, 2021 was $219.0 million, representing a net settlement asset of $0.7 million. The sensitivity analysis of changes in the fair value of our foreign exchange forward contracts outstanding as of March 31, 2021, while not predictive in nature, indicated that the net settlement asset of $0.7 million would decrease by $17.6 million resulting in a net settlement liability of $16.9 million, if the U.S. dollar uniformly weakened by 10% against all currencies covered by our contracts.

33

The sensitivity analysis described above recalculates the fair value of the foreign exchange forward contracts outstanding by replacing the actual foreign currency exchange rates and current month forward rates with foreign currency exchange rates and forward rates that reflect a 10% weakening of the U.S. dollar against all currencies covered by our contracts. All other factors are held constant. The sensitivity analysis disregards the possibility that currency exchange rates can move in opposite directions and that gains from one currency may or may not be offset by losses from another currency. The analysis also disregards the offsetting change in value of the underlying hedged transactions and balances.

The financial markets and currency volatility may limit our ability to cost-effectively hedge these exposures. The counterparties to derivative contracts are major financial institutions with investment grade credit ratings. We monitor the credit quality of these financial institutions on an ongoing basis.

Commodity Price Risk

We are exposed to commodity price risk with respect to certain materials and components used by us, our suppliers and our manufacturers, including polybutadiene, urethane and Surlyn for the manufacturing of our golf balls, titanium and steel for the assembly of our golf clubs, leather and synthetic fabrics for our golf shoes, golf gloves, golf gear and golf apparel, and resin and other petroleum-based materials for a number of our products.

Impact of Inflation

Our results of operations and financial condition are presented based on historical cost. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we believe the effects of inflation, if any, on our results of operations and financial condition have traditionally been immaterial. However, due to the uncertainty that exists with respect to the economic impact of the COVID-19 pandemic, our business, results of operations, financial position and cash flows could be materially impacted.

ITEM 4.      Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the fiscal quarter ended March 31, 2021. Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of such date, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. As a result of the COVID-19 pandemic, many of our employees began working remotely in March 2020 and continue to do so. This change to our working environment did not have a material effect on our internal controls over financial reporting during the most recent quarter. We will continue to monitor and assess any impacts from the COVID-19 pandemic on our internal controls over financial reporting.

34

PART II.         OTHER INFORMATION

ITEM 1.      Legal Proceedings

We are defendants in lawsuits associated with the normal conduct of our businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably.

Item 1A.      Risk Factors

You should carefully consider each of the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, as well as the other information set forth in this report. There have been no material changes to the risk factors as described in our Annual Report on Form 10-K for the year ended December 31, 2020.

ITEM 2.      Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information relating to the Company’s purchase of common stock for the first quarter of 2021:

Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Approximate dollar value of shares that may yet be purchased under the plans or programs (1)(2)  (in thousands)
January 1, 2021 - January 31, 2021	—	$	—	—	$	63,672
February 1, 2021 - February 28, 2021	—	—		—	63,672
March 1, 2021 - March 31, 2021	56,156	42.34		56,156	61,295
Total	56,156	$	42.34	56,156	$	61,295

_______________________________________________________________________________

(1)    Our Board of Directors has authorized us to repurchase up to an aggregate of $100.0 million of our issued and outstanding common stock. In connection with this share repurchase program, we entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of our common stock as we purchase on the open market up to an aggregate of $24.9 million at the same weighted average per share price. In relation to the Magnus share repurchase agreement, during the three months ended March 31, 2021 we recorded an additional $2.3 million liability for an additional 55,447 shares of common stock to be repurchased from Magnus, which are not included in the above table. The share repurchase program will remain in effect until completed or until terminated by the Board of Directors.

(2)    Includes $11.1 million related to the Magnus share repurchase agreement. See “Notes to Unaudited Condensed Consolidated Financial Statements-Note 10-Common Stock,” Item 1 of Part I, included elsewhere in this report, for disclosures related to the Magnus share repurchase agreement.

(3) On April 2, 2021, the Company repurchased from Magnus 355,341 shares of common stock for an aggregate of $11.1 million. At the completion of this transaction, the Company no longer had an obligation to repurchase shares of common stock from Magnus.

ITEM 3.      Defaults Upon Senior Securities

None.

ITEM 4.      Mine Safety Disclosures

None.

ITEM 5.      Other Information

None.

35

ITEM 6.      Exhibits

Exhibit No.	Description
31.1	Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2	Certification of Periodic Report by Chief Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.SCH	Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
104	Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

36

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ACUSHNET HOLDINGS CORP.
Dated: May 6, 2021	By:	/s/ David Maher
		David Maher
		President and Chief Executive Officer
		(Principal Executive Officer)
Dated: May 6, 2021	By:	/s/ Thomas Pacheco
		Thomas Pacheco
		Executive Vice President, Chief Financial Officer and Chief Accounting Officer
		(Principal Financial Officer and Principal Accounting Officer)

37

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, David Maher, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Acushnet Holdings Corp.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2021

/s/ DAVID MAHER

Name: David Maher

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Thomas Pacheco, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Acushnet Holdings Corp.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2021

/s/ THOMAS PACHECO

Name: Thomas Pacheco

Executive Vice President, Chief Financial Officer and Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF PERIODIC FINANCIAL REPORTS

I, David Maher, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)the Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Acushnet Holdings Corp.

Date: May 6, 2021

/s/ DAVID MAHER

Name: David Maher

President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION OF PERIODIC FINANCIAL REPORTS

I, Thomas Pacheco, Executive Vice President, Chief Financial Officer and Chief Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Acushnet Holdings Corp.

Date: May 6, 2021

/s/ THOMAS PACHECO

Name: Thomas Pacheco

Executive Vice President, Chief Financial Officer and Chief Accounting Officer

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	Apr. 30, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	001-37935
Entity Registrant Name	Acushnet Holdings Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-2644353
Entity Address, Address Line One	333 Bridge Street
Entity Address, City or Town	Fairhaven,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02719
City Area Code	800
Local Phone Number	225-8500
Title of 12(b) Security	Common Stock - $0.001 par value per share
Trading Symbol	GOLF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		74,063,851
Entity Central Index Key	0001672013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash, cash equivalents and restricted cash ($8,666 and $6,843 attributable to the variable interest entity ("VIE"))	$ 113,047	$ 151,452
Accounts receivable, net	387,507	201,518
Inventories ($11,046 and $13,830 attributable to the VIE)	330,165	357,682
Prepaid and other assets	92,343	89,155
Total current assets	923,062	799,807
Property, plant and equipment, net ($10,319 and $10,538 attributable to the VIE)	220,616	222,811
Goodwill ($32,312 and $32,312 attributable to the VIE)	213,555	215,186
Intangible assets, net	471,394	473,533
Deferred income taxes	66,697	80,060
Other assets ($2,220 and $2,239 attributable to the VIE)	73,558	75,158
Total assets	1,968,882	1,866,555
Current liabilities
Short-term debt	24,696	2,810
Current portion of long-term debt	17,500	17,500
Accounts payable ($5,714 and $8,702 attributable to the VIE)	125,865	112,867
Accrued taxes	54,575	40,952
Accrued compensation and benefits ($852 and $1,454 attributable to the VIE)	67,693	82,290
Accrued expenses and other liabilities ($3,467 and $3,699 attributable to the VIE)	108,468	101,260
Total current liabilities	398,797	357,679
Long-term debt	309,524	313,619
Deferred income taxes	3,797	3,821
Accrued pension and other postretirement benefits	121,811	121,929
Other noncurrent liabilities ($2,276 and $2,261 attributable to the VIE)	48,876	52,128
Total liabilities	882,805	849,176
Commitments and contingencies (Note 15)
Redeemable noncontrolling interest	97	126
Shareholders' equity
Common stock, $0.001 par value, 500,000,000 shares authorized; 75,847,208 and 75,666,367 shares issued	76	76
Additional paid-in capital	926,809	925,385
Accumulated other comprehensive loss, net of tax	(98,160)	(96,182)
Retained earnings	271,967	199,776
Treasury stock, at cost; 1,783,357 and 1,671,754 shares (including 355,341 and 299,894 of accrued share repurchases) (Note 10)	(49,830)	(45,106)
Total equity attributable to Acushnet Holdings Corp.	1,050,862	983,949
Noncontrolling interests	35,118	33,304
Total shareholders' equity	1,085,980	1,017,253
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 1,968,882	$ 1,866,555

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Cash and restricted cash	$ 113,047	$ 151,452
Inventories	330,165	357,682
Property, plant and equipment, net	220,616	222,811
Goodwill	213,555	215,186
Other assets	73,558	75,158
Accounts payable	125,865	112,867
Accrued compensation and benefits	67,693	82,290
Accrued expenses and other liabilities	108,468	101,260
Other noncurrent liabilities	$ 48,876	$ 52,128
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	75,847,208	75,666,367
Treasury stock, at cost (in shares)	1,783,357	1,671,754
Accrued share repurchase (in shares)	355,341	299,894
VIE
Cash and restricted cash	$ 8,666	$ 6,843
Inventories	11,046	13,830
Property, plant and equipment, net	10,319	10,538
Goodwill	32,312	32,312
Other assets	2,220	2,239
Accounts payable	5,714	8,702
Accrued compensation and benefits	852	1,454
Accrued expenses and other liabilities	3,467	3,699
Other noncurrent liabilities	$ 2,276	$ 2,261

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net sales	$ 580,885	$ 408,741
Cost of goods sold	270,146	207,786
Gross profit	310,739	200,955
Operating expenses:
Selling, general and administrative	176,369	152,723
Research and development	12,329	13,220
Intangible amortization	1,972	1,956
Restructuring charges	0	11,628
Income from operations	120,069	21,428
Interest expense, net	3,616	4,123
Other expense, net	1,992	690
Income before income taxes	114,461	16,615
Income tax expense	27,834	7,640
Net income	86,627	8,975
Less: Net income attributable to noncontrolling interests	(1,669)	(98)
Net income attributable to Acushnet Holdings Corp.	$ 84,958	$ 8,877
Net income per common share attributable to Acushnet Holdings Corp.:
Basic (in dollars per share)	$ 1.14	$ 0.12
Diluted (in dollars per share)	$ 1.13	$ 0.12
Weighted average number of common shares:
Basic (in shares)	74,778,189	74,545,280
Diluted (in shares)	75,255,312	75,099,930

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 86,627	$ 8,975
Other comprehensive income (loss):
Foreign currency translation adjustments	(7,080)	(22,783)
Cash flow derivative instruments:
Unrealized holding gains arising during period	4,367	7,402
Reclassification adjustments included in net income	563	(1,724)
Tax expense	(1,664)	(1,848)
Cash flow derivative instruments, net	3,266	3,830
Pension and other postretirement benefits:
Pension and other postretirement benefits adjustments	2,575	1,690
Tax expense	(739)	(368)
Pension and other postretirement benefits adjustments, net	1,836	1,322
Total other comprehensive loss	(1,978)	(17,631)
Comprehensive income (loss)	84,649	(8,656)
Less: Comprehensive income attributable to noncontrolling interests	(1,529)	(118)
Comprehensive income (loss) attributable to Acushnet Holdings Corp.	$ 83,120	$ (8,774)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income	$ 86,627	$ 8,975
Adjustments to reconcile net income to cash flows used in operating activities
Depreciation and amortization	10,363	10,269
Unrealized foreign exchange gains	(3,593)	(200)
Amortization of debt issuance costs	917	213
Share-based compensation	5,533	2,187
Loss (gain) on disposals of property, plant and equipment	155	(2)
Deferred income taxes	10,265	(1,194)
Changes in operating assets and liabilities
Accounts receivable	(190,019)	(102,181)
Inventories	24,987	19,092
Accounts payable	13,788	(2,652)
Accrued taxes	15,039	(2,125)
Other assets and liabilities	(4,058)	(4,894)
Cash flows used in operating activities	(29,996)	(72,512)
Cash flows from investing activities
Additions to property, plant and equipment	(6,410)	(5,741)
Cash flows used in investing activities	(6,410)	(5,741)
Cash flows from financing activities
Proceeds from short-term borrowings, net	22,178	125,133
Repayments of term loan facility	(4,375)	(4,375)
Purchases of common stock	(2,377)	(6,976)
Debt issuance costs	0	(14)
Dividends paid on common stock	(12,658)	(11,521)
Dividends paid to noncontrolling interests	(48)	0
Payment of employee restricted stock tax withholdings	(3,946)	(380)
Cash flows (used in) provided by financing activities	(1,226)	101,867
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(773)	(1,874)
Net (decrease) increase in cash, cash equivalents and restricted cash	(38,405)	21,740
Cash, cash equivalents and restricted cash, beginning of year	151,452	34,184
Cash, cash equivalents and restricted cash, end of period	113,047	55,924
Supplemental information
Non-cash additions to property, plant and equipment	1,895	1,161
Non-cash additions to right-of-use assets obtained in exchange for operating lease obligations	1,291	2,020
Non-cash additions to right-of-use assets obtained in exchange for finance lease obligations	0	357
Dividend equivalents rights ("DERs") declared not paid	477	231
Share repurchase liability (Note 10)	$ 2,347	$ 6,976

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Total Shareholders' Equity Attributable to Acushnet Holdings Corp.	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss, Net of Tax	Retained Earnings	Treasury Stock	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2019			75,620
Beginning balance at Dec. 31, 2019	$ 950,826	$ 918,440	$ 76	$ 910,507	$ (112,028)	$ 151,039	$ (31,154)	$ 32,386
Changes in stockholders' equity
Net income	9,401	8,877				8,877		524
Other comprehensive loss	(17,631)	(17,631)			(17,631)
Share-based compensation	2,023	2,023		2,023
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			29
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	(368)	(368)		(368)
Purchases of common stock (Note 10)	(6,976)	(6,976)					(6,976)
Share repurchase liability (Note 10)	(6,976)	(6,976)					(6,976)
Dividends and dividend equivalents declared	(11,735)	(11,735)				(11,735)
Ending balance (in shares) at Mar. 31, 2020			75,649
Ending balance at Mar. 31, 2020	918,564	885,654	$ 76	912,162	(129,659)	148,181	(45,106)	32,910
Beginning balance (in shares) at Dec. 31, 2019			75,620
Beginning balance at Dec. 31, 2019	950,826	918,440	$ 76	910,507	(112,028)	151,039	(31,154)	32,386
Changes in stockholders' equity
Dividends and dividend equivalents declared	(47,269)
Ending balance (in shares) at Dec. 31, 2020			75,666
Ending balance at Dec. 31, 2020	1,017,253	983,949	$ 76	925,385	(96,182)	199,776	(45,106)	33,304
Changes in stockholders' equity
Net income	86,820	84,958				84,958		1,862
Other comprehensive loss	(1,978)	(1,978)			(1,978)
Share-based compensation	5,369	5,369		5,369
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			181
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	(3,945)	(3,945)		(3,945)
Purchases of common stock (Note 10)	(2,377)	(2,377)					(2,377)
Share repurchase liability (Note 10)	(2,347)	(2,347)					(2,347)
Dividends and dividend equivalents declared	(12,767)	(12,767)				(12,767)
Dividends declared to noncontrolling interests	(48)							(48)
Ending balance (in shares) at Mar. 31, 2021			75,847
Ending balance at Mar. 31, 2021	$ 1,085,980	$ 1,050,862	$ 76	$ 926,809	$ (98,160)	$ 271,967	$ (49,830)	$ 35,118

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.

Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of results to be expected for the full year ending December 31, 2021, nor were those of the comparable 2020 period representative of those actually experienced for the full year ended December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2020 included in its Annual Report on Form 10-K filed with the SEC on February 25, 2021.

Risks and Uncertainties

In March 2020, the World Health Organization declared a pandemic related to the novel coronavirus (“COVID-19”), which led to government-ordered shutdowns of non-essential businesses, travel restrictions and restrictions on public gatherings. As a result of the government-ordered shutdowns, the Company was forced to temporarily close or substantially limit operations in its manufacturing facilities and distribution centers in the United States and Europe from mid-March 2020 through mid-May 2020, which disrupted business to varying degrees across many regions. The Company's manufacturing facilities and distribution centers reopened in mid-May 2020 and substantially all golf courses, on-course retail pro shops and off-course retail partner locations in the United States and Europe reopened by June 2020. The game of golf experienced a surge in rounds of play around the world primarily during the second half of 2020, in part due to its outdoor field of play and ease of social distancing, and rounds of play remained high through the first quarter of 2021.

While government-ordered shutdowns and restrictions have eased in most regions and mass vaccination programs are underway, it is nevertheless possible that a resurgence of positive cases could prompt a return to tighter restrictions in certain regions, as with the lockdown in the United Kingdom during the first quarter of 2021. While the Company has seen increased rounds of play and demand for golf and golf-related products, as mass vaccinations programs advance and restrictions are further eased on other activities, the increase in rounds of play and demand for golf-related products could decrease.

The Company has evaluated and continues to evaluate the potential impact of the COVID-19 pandemic on its consolidated financial statements. The impact of the COVID-19 pandemic continues to evolve, and both the full impact and duration of the COVID-19 pandemic remain highly uncertain. Accordingly, the Company's business, results of operations, financial position and cash flows could be materially impacted in ways that the Company cannot currently predict.

Use of Estimates

The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company has also made estimates related to the impact of the COVID-19 pandemic within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods. Actual results could differ from these estimates.

Variable Interest Entities

VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE.

The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2021 and December 31, 2020. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.

Noncontrolling Interests and Redeemable Noncontrolling Interest

The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The financial results and position of the noncontrolling interests are included in their entirety in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. The value attributable to the redeemable noncontrolling interest and the related loan to the minority shareholders, which is recorded as a reduction to redeemable noncontrolling interest, is presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders included in temporary equity on the unaudited condensed consolidated balance sheets was $4.4 million as of both March 31, 2021 and December 31, 2020. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.

Cash, Cash Equivalents and Restricted Cash

Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of both March 31, 2021 and December 31, 2020, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $2.0 million.

Foreign Currency Translation and Transactions

Foreign currency transaction losses included in selling, general and administrative expense were $1.0 million for each of the three months ended March 31, 2021 and 2020.

Recently Adopted Accounting Standards

Income Taxes

On January 1, 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). The amendments in this update simplified the accounting for income taxes by removing certain exceptions to general principles in Topic 740. The amendments also improved consistent application and simplified U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a material impact on the consolidated financial statements.

XML

Accounts Receivable

3 Months Ended

Mar. 31, 2021

Receivables [Abstract]

Accounts Receivable

Accounts Receivable

The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions (including the impact of the COVID-19 pandemic) which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses.

The activity related to the allowance for doubtful accounts for the periods presented was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	7,698	$	5,338
Bad debt (recovery) expense	(445)		916
Amount of receivables written off	(144)		(286)
Foreign currency translation and other	(32)		(186)
Balance at end of period	$	7,077	$	5,782

XML

Inventories

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

The components of inventories were as follows: 

	March 31,		December 31,
(in thousands)	2021		2020
Raw materials and supplies	$	73,080	$	74,302
Work-in-process	25,077		22,913
Finished goods	232,008		260,467
Inventories	$	330,165	$	357,682

XML

Product Warranty

3 Months Ended

Mar. 31, 2021

Product Warranties Disclosures [Abstract]

Product Warranty

Product Warranty

The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.

The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	3,831	$	4,048
Provision	1,029		1,209
Claims paid/costs incurred	(918)		(944)
Foreign currency translation and other	(43)		(164)
Balance at end of period	$	3,899	$	4,149

XML

Debt and Financing Arrangements

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Debt and Financing Arrangements

Debt and Financing Arrangements

Credit Facility

The credit facility includes a revolving credit facility and a term loan facility. There were outstanding borrowings under the revolving credit facility of $15.9 million as of March 31, 2021. The weighted average interest rate applicable to these outstanding borrowings was 1.79% as of March 31, 2021. There were no outstanding borrowings under the revolving credit facility as of December 31, 2020. As of March 31, 2021, the Company had available borrowings under its revolving credit facility of $376.0 million after giving effect to $8.1 million of outstanding letters of credit.

On July 3, 2020, the Company amended its credit agreement dated December 23, 2019 (the “First Amendment”) to, among other things, modify the maximum net average total leverage ratio, the interest rate margins, commitment fee and covenant baskets for each of the fiscal quarters ending after June 30, 2020 and on or before September 30, 2021 (the “Covenant

Relief Period”). On March 5, 2021, the Company issued a notice exercising its right to an early termination of the Covenant Relief Period and as such is now required to comply with the previous maximum net average total leverage ratio, and the interest rate margins, commitment fee and covenant baskets reverted to the levels in effect prior to the First Amendment as discussed below. In connection with terminating the Covenant Relief Period, the Company recorded additional interest expense of approximately $0.7 million related to the acceleration of unamortized debt issuance costs for the three months ended March 31, 2021.

Borrowings under the credit facility bear interest at a rate per annum equal to, at the applicable Borrower’s option, either (a) a base rate determined by reference to the highest of (1) the prime rate of Wells Fargo, (2) the federal funds effective rate plus 0.50% and (3) a Eurodollar Rate, subject to certain adjustments, plus 1.00% or (b) a Eurodollar Rate (or, in the case of Canadian borrowings, a Canadian Dollar Offered Rate), subject to certain adjustments, in each case, plus an applicable margin. Under the credit agreement, the applicable margin is 0% to 0.75% for base rate borrowings and 1.00% to 1.75% for Eurodollar rate or Canadian Dollar Offered Rate borrowings, in each case, depending on the Net Average Total Leverage Ratio (as defined in the credit agreement). In addition, the Company is required to pay a commitment fee on any unutilized commitments under the revolving credit facility. The commitment fee rate payable in respect of unused portions of the revolving credit facility is 0.15% to 0.30% per annum, depending on the Net Average Total Leverage Ratio. The initial commitment fee rate is 0.20% per annum. The maximum net average total leverage ratio under the credit facility is 3.50 to 1.00, which is subject to increase to 3.75 to 1.00 in connection with certain acquisitions, and the minimum consolidated interest coverage ratio (as defined in the credit agreement) is 3.00 to 1.00.

The credit agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2021, the Company was in compliance with all covenants under the credit agreement.

Other Short-Term Borrowings

The Company has certain unsecured local credit facilities available through its subsidiaries. There were outstanding borrowings under the Company's local credit facilities of $8.8 million and $2.8 million as of March 31, 2021 and December 31, 2020, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.28% and 2.00% as of March 31, 2021 and December 31, 2020, respectively. As of March 31, 2021, the Company had available borrowings remaining under these local credit facilities of $50.3 million.

Letters of Credit

As of March 31, 2021 and December 31, 2020, there were outstanding letters of credit related to agreements, including the Company's credit facility, totaling $11.8 million and $11.7 million, respectively, of which $8.6 million and $8.3 million, respectively, was secured. These agreements provided a maximum commitment for letters of credit of $53.7 million as of March 31, 2021.

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial InstrumentsThe Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.

Foreign Exchange Derivative Instruments

Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2021 and December 31, 2020 was $219.0 million and $248.1 million, respectively.

As a result of the impact of the COVID-19 pandemic, during the three months ended March 31, 2020, the Company de-designated certain foreign exchange cash flow hedges deemed ineffective, none of which were outstanding as of March 31, 2021 or December 31, 2020.

The Company also enters into foreign exchange forward contracts, which do not qualify as hedging instruments, to reduce foreign currency transaction risk related to certain intercompany assets and liabilities denominated in a currency other than functional currency. These undesignated instruments are recorded at fair value as a derivative asset or liability with the corresponding change in fair value recognized in selling, general and administrative expense. There were no outstanding foreign exchange forward contracts not designated under hedge accounting as of March 31, 2021 and December 31, 2020.

Interest Rate Derivative Instruments

The Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. The interest rate swap contracts are accounted for as cash flow hedges. As of March 31, 2021 and December 31, 2020, the notional value of the Company's outstanding interest rate swap contracts was $140.0 million.

Impact on Financial Statements

The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Hedge Instrument Type	2021		2020
Prepaid and other assets	Foreign exchange forward	$	3,476	$	1,166
Other assets	Foreign exchange forward	1,225		30
Accrued expenses and other liabilities	Foreign exchange forward	3,929		6,400
	Interest rate swap	621		1,571
Other noncurrent liabilities	Foreign exchange forward	92		985

The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Type of hedge
Foreign exchange forward	$	4,376	$	9,467
Interest rate swap	(9)		(2,065)
Total	$	4,367	$	7,402

Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net loss of $3.2 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold and a net loss of $0.6 million related to interest rate derivative instruments from accumulated other comprehensive loss, net of tax into interest expense, net. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.

The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Location of gain (loss) in statement of operations
Foreign exchange forward:
Cost of goods sold	$	396	$	1,542
Selling, general and administrative (1)(2)	640		1,534
Total	$	1,036	$	3,076
Interest Rate Swap:
Interest expense, net	$	(959)	$	(478)
Total	$	(959)	$	(478)

_______________________________________________________________________________

(1)    Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.

(2)    Selling, general and administrative expense for the three months ended March 31, 2020 excludes net gains of $0.7 million reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective.

Credit Risk

The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

Assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 were as follows:

	Fair Value Measurements as of
	March 31, 2021 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,046	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		3,476		—		Prepaid and other assets
Deferred compensation program assets	803		—		—		Other assets
Foreign exchange derivative instruments	—		1,225		—		Other assets
Total assets	$	5,849	$	4,701	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	3,929	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		621		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	803		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		92		—		Other noncurrent liabilities
Total liabilities	$	803	$	4,642	$	—

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 were as follows:

	Fair Value Measurements as of
	December 31, 2020 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,160	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		1,166		—		Prepaid and other assets
Deferred compensation program assets	802		—		—		Other assets
Foreign exchange derivative instruments	—		30		—		Other assets
Total assets	$	5,962	$	1,196	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	6,400	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		1,571		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	802		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		985		—		Other noncurrent liabilities
Total liabilities	$	802	$	8,956	$	—

Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.

Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.

Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.

Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve.

XML

Pension and Other Postretirement Benefits

3 Months Ended

Mar. 31, 2021

Retirement Benefits [Abstract]

Pension and Other Postretirement Benefits

Pension and Other Postretirement Benefits

Components of net periodic benefit cost (income) were as follows: 

	Pension Benefits				Postretirement Benefits
	Three months ended March 31,
(in thousands)	2021		2020		2021		2020
Components of net periodic benefit cost
Service cost	$	2,135	$	2,316	$	162	$	171
Interest cost	1,951		2,512		75		112
Expected return on plan assets	(2,547)		(2,903)		—		—
Settlement expense	1,419		—		—		—
Amortization of net loss (gain)	1,421		964		(65)		(214)
Amortization of prior service cost (credit)	71		70		(34)		(34)
Net periodic benefit cost	$	4,450	$	2,959	$	138	$	35

The non-service cost components of net periodic benefit cost (income) are included in other expense, net in the unaudited condensed consolidated statements of operations.

XML

Income Taxes

3 Months Ended

Mar. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Income tax expense increased by $20.2 million to $27.8 million for the three months ended March 31, 2021 compared to $7.6 million for the three months ended March 31, 2020. The Company’s effective tax rate ("ETR") was 24.3% for the three months ended March 31, 2021 compared to 46.0% for the three months ended March 31, 2020.

The ETR for the three months ended March 31, 2021 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income and the geographic mix of income earned by the Company's international subsidiaries, partially offset by the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits.

The ETR for the three months ended March 31, 2020 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income, the geographic mix of income earned by the Company's international subsidiaries and the effect of foreign currency losses that could not be benefited.

XML

Common Stock

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Common Stock

Common Stock

Dividends

The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:

	Dividends per Common Share		Amount (in thousands)
2021:
First Quarter	$	0.165	$	12,767
Total dividends declared in 2021	$	0.165	$	12,767
2020:
Fourth Quarter	$	0.155	$	11,983
Third Quarter	0.155		11,790
Second Quarter	0.155		11,761
First Quarter	0.155		11,735
Total dividends declared in 2020	$	0.620	$	47,269

During the second quarter of 2021, the Company's Board of Directors declared a dividend of $0.165 per share of common stock to shareholders of record as of June 4, 2021 and payable on June 18, 2021.

Share Repurchase Program

As of March 31, 2021, the Board of Directors had authorized the Company to repurchase up to an aggregate of $100.0 million of its issued and outstanding common stock. In April 2020, the Company temporarily suspended stock repurchases under its share repurchase program in light of the COVID-19 pandemic. In March 2021, the Company resumed share repurchases under its share repurchase program.

Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Company’s credit agreement. As previously disclosed, in connection with this share repurchase program, the Company entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly-owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of its common stock as it purchases on the open market, up to an aggregate of $24.9 million, at the same weighted average per share price.

The Company's share repurchase activity was as follows:

	Three months ended March 31,
(in thousands, except share and per share amounts)	2021		2020
Shares repurchased in the open market:
Shares repurchased	56,156		243,894
Average price	$	42.34	$	28.60
Aggregate value	$	2,377	$	6,976

In relation to the Magnus share repurchase agreement, the Company recorded a share repurchase liability of $11.1 million and $8.8 million for 355,341 and 299,894 shares of common stock to be repurchased from Magnus, which was included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheets as of March 31, 2021 and December 31, 2020, respectively. Excluding the impact of the share repurchase liability, as of March 31, 2021, the Company had $61.3 million remaining under the current share repurchase authorization, including $11.1 million related to the Magnus share repurchase agreement.

As the Company repurchased a cumulative total of $24.9 million of common stock through open market purchases, the determination date, as defined in the Magnus share repurchase agreement, was automatically triggered on March 18, 2021. As a result, on April 2, 2021, the Company repurchased from Magnus 355,341 shares of common stock for an aggregate $11.1 million. At the completion of this transaction, the Company no longer had an obligation to repurchase shares of common stock from Magnus.

XML

Equity Incentive Plans

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Equity Incentive Plans

Equity Incentive Plans

Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (“2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the Board of Directors, officers, employees, consultants and advisors of the Company. As of March 31, 2021, the only awards granted under the 2015 Plan were RSUs and PSUs.

Restricted Stock and Performance Stock Units

RSUs granted to members of the Board of Directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally over three years, subject to the recipient’s continued service to the Company. PSUs vest, subject to the recipient's continued employment with the Company, based upon the Company's performance against specified metrics which are generally over a three year performance period. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these metrics. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.

All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.

A summary of the Company’s RSUs and PSUs as of March 31, 2021 and changes during the three months then ended is presented below: 

		Weighted-			Weighted-
	Number	Average		Number	Average
	of RSUs	Fair Value RSUs		of PSUs	Fair Value PSUs
Outstanding as of December 31, 2020	1,253,173	$	24.33	457,576	$	24.55
Granted	289,259	45.36		145,110	45.36
Vested (1)	(362,605)	24.11		—	—
Forfeited	(20,290)	24.24		(2,631)	25.45
Outstanding as of March 31, 2021	1,159,537	$	29.65	600,055	$	29.58

_______________________________________________________________________________

(1) Includes 110,514 shares of common stock related to RSUs and no shares of common stock related to PSUs that were not delivered as of March 31, 2021.

A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:

	Three months ended		Three months ended
	March 31, 2021		March 31, 2020
	RSUs	PSUs	RSUs	PSUs
Shares of common stock issued	270,779	—	42,797	—
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations	(89,938)	—	(13,831)	—
Net shares of common stock issued	180,841	—	28,966	—
Cumulative undelivered shares of common stock	395,670	—	240,512	—

Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
RSUs	$	2,359	$	2,478
PSUs	3,010		(455)

During the three months ended March 31, 2020, the Company adjusted the estimate of its performance against metrics for certain PSUs downward, resulting in a reversal of previously recognized share-based compensation expense. During both the second half of 2020 and the three months ended March 31, 2021, based on updated forecast information, the Company increased the estimate of its performance against metrics for these PSUs and recognized additional cumulative share-based compensation expense in both periods.

The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $23.4 million and $13.0 million, respectively, as of March 31, 2021 and is expected to be recognized over the related weighted average period of 2.3 years and 2.2 years, respectively.

Compensation Expense

The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Cost of goods sold	$	(7)	$	225
Selling, general and administrative	5,381		1,714
Research and development	159		248
Total compensation expense before income tax	5,533		2,187
Income tax benefit	1,267		463
Total compensation expense, net of income tax	$	4,266	$	1,724

XML

Accumulated Other Comprehensive Loss, Net of Tax

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Accumulated Other Comprehensive Loss, Net of Tax

Accumulated Other Comprehensive Loss, Net of Tax

Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).

The components of and changes in accumulated other comprehensive loss, net of tax, were as follows:

	Foreign		Gains (Losses) on		Gains (Losses) on		Pension and		Accumulated
	Currency		Foreign Exchange		Interest Rate		Other		Other
	Translation		Derivative		Swap Derivative		Postretirement		Comprehensive
(in thousands)	Adjustments		Instruments		Instruments		Adjustments		Loss, Net of Tax
Balance as of December 31, 2020	$	(43,906)	$	(4,471)	$	(1,179)	$	(46,626)	$	(96,182)
Other comprehensive income (loss) before reclassifications	(7,080)		4,376		(9)		(237)		(2,950)
Amounts reclassified from accumulated other comprehensive loss, net of tax	—		(396)		959		2,812		3,375
Tax expense	—		(1,435)		(229)		(739)		(2,403)
Balance as of March 31, 2021	$	(50,986)	$	(1,926)	$	(458)	$	(44,790)	$	(98,160)

XML

Net Income per Common Share

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Net Income per Common Share

Net Income per Common Share

The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:

	Three months ended
	March 31,
(in thousands, except share and per share amounts)	2021		2020
Net income attributable to Acushnet Holdings Corp.	$	84,958	$	8,877
Weighted average number of common shares:
Basic	74,778,189		74,545,280
Diluted	75,255,312		75,099,930
Net income per common share attributable to Acushnet Holdings Corp.:
Basic	$	1.14	$	0.12
Diluted	$	1.13	$	0.12

Net income per common share attributable to Acushnet Holdings Corp. for the three months ended March 31, 2021 and 2020 was calculated using the treasury stock method.

The Company’s potential dilutive securities for the three months ended March 31, 2021 and 2020 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement.

For the three months ended March 31, 2021 and 2020, the following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:

	Three months ended
	March 31,
	2021	2020
RSUs	291,484	—

XML

Segment Information

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company’s operating segments are based on how the Chief Operating Decision Maker (“CODM”) makes decisions about assessing performance and allocating resources. The Company has four reportable segments that are organized on the basis of product categories. These segments include Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear.

The CODM primarily evaluates performance using segment operating income (loss). Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes interest expense, net, restructuring charges, the non-service cost component of net periodic benefit cost, transaction fees and other non-operating gains and losses as the Company does not allocate these to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance.

Results shown for the three months ended March 31, 2021 and 2020 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions.

Information by reportable segment and a reconciliation to reported amounts are as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Net sales
Titleist golf balls	$	173,637	$	116,239
Titleist golf clubs	155,827		93,214
Titleist golf gear	53,120		43,525
FootJoy golf wear	159,434		130,387
Other	38,867		25,376
Total net sales	$	580,885	$	408,741
Segment operating income
Titleist golf balls	$	34,317	$	3,243
Titleist golf clubs	41,799		4,503
Titleist golf gear	9,728		8,865
FootJoy golf wear	28,117		14,297
Other	6,471		1,080
Total segment operating income	120,432		31,988
Reconciling items:
Interest expense, net	(3,616)		(4,123)
Restructuring charges	—		(11,628)
Non-service cost component of net periodic benefit cost	(2,291)		(507)
Other	(64)		885
Total income before income tax	$	114,461	$	16,615

Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.

	Three months ended March 31,
(in thousands)	2021		2020
United States	$	308,636	$	211,008
EMEA (1)	80,575		74,671
Japan	56,377		37,556
Korea	79,097		50,449
Rest of world	56,200		35,057
Total net sales	$	580,885	$	408,741

_______________________________________________________________________________

(1) Europe, the Middle East and Africa ("EMEA")

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Purchase Obligations

During the normal course of its business, the Company enters into agreements to purchase goods and services, including purchase commitments for production materials, finished goods inventory, capital expenditures and endorsement arrangements with professional golfers.

The Company's purchase obligations as of March 31, 2021 were as follows:

	Payments Due by Period
	Remainder of
(in thousands)	2021		2022		2023		2024		2025		Thereafter
Purchase obligations (1)	$	200,097	$	16,026	$	3,282	$	2,545	$	2,549	$	1,284

_______________________________________________________________________________

(1)    The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2021.

Litigation

The Company and its subsidiaries are defendants in lawsuits associated with the normal conduct of their businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably. Consequently, the Company is unable to estimate the ultimate aggregate amount of monetary loss, amounts covered by insurance or the financial impact that will result from such matters and has not recorded a liability related to potential losses.

XML

Restructuring Charges

3 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

Restructuring Charges

Restructuring Charges

During the first quarter of 2020, management approved a restructuring program to refine its business model and improve operational efficiencies. This program included both a voluntary bridge to retirement ("VBR") program for certain eligible employees and involuntary headcount reductions ("Other"). The VBR program was part of the Company's long-term strategic planning process and was designed to bridge eligible employees to retirement. As part of this program, employees were offered severance in the form of salary continuation, including benefits, as well as accrued bonus incentives. Costs associated with the involuntary headcount reductions include severance and other benefits related to these headcount reductions. The Company recorded cumulative severance and other benefits expense of $11.2 million related to its VBR program and $2.0 million related to its Other restructuring program, of which $11.2 million and $0.4 million was recorded during the three months ended March 31, 2020 related to the VBR program and Other program, respectively. There are no further costs expected to be incurred in relation to these programs.

The activity related to the Company’s restructuring programs was as follows:

	Three months ended March 31, 2021
(in thousands)	VBR		Other
Balance at beginning of period	$	6,243	$	778
Payments	(2,161)		(565)
Foreign currency translation and other	—		(1)
Balance at end of period	$	4,082	$	212

The restructuring program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Restructuring Program	2021		2020
Accrued compensation and benefits	VBR	$	4,039	$	6,018
	Other	212		778
Other noncurrent liabilities	VBR	43		225

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.

Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of results to be expected for the full year ending December 31, 2021, nor were those of the comparable 2020 period representative of those actually experienced for the full year ended December 31, 2020. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2020 included in its Annual Report on Form 10-K filed with the SEC on February 25, 2021.

Use of Estimates

Use of Estimates

The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company has also made estimates related to the impact of the COVID-19 pandemic within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods. Actual results could differ from these estimates.

Variable Interest Entities

Variable Interest Entities

VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE.

The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2021 and December 31, 2020. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.

Noncontrolling Interests and Redeemable Noncontrolling Interest

Noncontrolling Interests and Redeemable Noncontrolling Interest

The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The financial results and position of the noncontrolling interests are included in their entirety in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. The value attributable to the redeemable noncontrolling interest and the related loan to the minority shareholders, which is recorded as a reduction to redeemable noncontrolling interest, is presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders included in temporary equity on the unaudited condensed consolidated balance sheets was $4.4 million as of both March 31, 2021 and December 31, 2020. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.

Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted CashCash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations.

Foreign Currency Translation and Transactions

Foreign Currency Translation and Transactions

Foreign currency transaction losses included in selling, general and administrative expense were $1.0 million for each of the three months ended March 31, 2021 and 2020.

Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

Income Taxes

On January 1, 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). The amendments in this update simplified the accounting for income taxes by removing certain exceptions to general principles in Topic 740. The amendments also improved consistent application and simplified U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The adoption of this standard did not have a material impact on the consolidated financial statements.

Accounts Receivable

The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions (including the impact of the COVID-19 pandemic) which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses.

XML

Accounts Receivable (Tables)

3 Months Ended

Mar. 31, 2021

Receivables [Abstract]

Activity Related to the Allowance for Doubtful Accounts

The activity related to the allowance for doubtful accounts for the periods presented was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	7,698	$	5,338
Bad debt (recovery) expense	(445)		916
Amount of receivables written off	(144)		(286)
Foreign currency translation and other	(32)		(186)
Balance at end of period	$	7,077	$	5,782

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Schedule of Inventory

The components of inventories were as follows: 

	March 31,		December 31,
(in thousands)	2021		2020
Raw materials and supplies	$	73,080	$	74,302
Work-in-process	25,077		22,913
Finished goods	232,008		260,467
Inventories	$	330,165	$	357,682

XML

Product Warranty (Tables)

3 Months Ended

Mar. 31, 2021

Product Warranties Disclosures [Abstract]

Schedule of Warranty Obligation for Accrued Warranty Expense

The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Balance at beginning of period	$	3,831	$	4,048
Provision	1,029		1,209
Claims paid/costs incurred	(918)		(944)
Foreign currency translation and other	(43)		(164)
Balance at end of period	$	3,899	$	4,149

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets

The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Hedge Instrument Type	2021		2020
Prepaid and other assets	Foreign exchange forward	$	3,476	$	1,166
Other assets	Foreign exchange forward	1,225		30
Accrued expenses and other liabilities	Foreign exchange forward	3,929		6,400
	Interest rate swap	621		1,571
Other noncurrent liabilities	Foreign exchange forward	92		985

Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax

The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Type of hedge
Foreign exchange forward	$	4,376	$	9,467
Interest rate swap	(9)		(2,065)
Total	$	4,367	$	7,402

Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations

The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Location of gain (loss) in statement of operations
Foreign exchange forward:
Cost of goods sold	$	396	$	1,542
Selling, general and administrative (1)(2)	640		1,534
Total	$	1,036	$	3,076
Interest Rate Swap:
Interest expense, net	$	(959)	$	(478)
Total	$	(959)	$	(478)

_______________________________________________________________________________

(1)    Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.

(2)    Selling, general and administrative expense for the three months ended March 31, 2020 excludes net gains of $0.7 million reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective.

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 were as follows:

	Fair Value Measurements as of
	March 31, 2021 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,046	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		3,476		—		Prepaid and other assets
Deferred compensation program assets	803		—		—		Other assets
Foreign exchange derivative instruments	—		1,225		—		Other assets
Total assets	$	5,849	$	4,701	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	3,929	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		621		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	803		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		92		—		Other noncurrent liabilities
Total liabilities	$	803	$	4,642	$	—

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 were as follows:

	Fair Value Measurements as of
	December 31, 2020 using:
(in thousands)	Level 1		Level 2		Level 3		Balance Sheet Location
Assets
Rabbi trust	$	5,160	$	—	$	—	Prepaid and other assets
Foreign exchange derivative instruments	—		1,166		—		Prepaid and other assets
Deferred compensation program assets	802		—		—		Other assets
Foreign exchange derivative instruments	—		30		—		Other assets
Total assets	$	5,962	$	1,196	$	—
Liabilities
Foreign exchange derivative instruments	$	—	$	6,400	$	—	Accrued expenses and other liabilities
Interest rate derivative instruments	—		1,571		—		Accrued expenses and other liabilities
Deferred compensation program liabilities	802		—		—		Other noncurrent liabilities
Foreign exchange derivative instruments	—		985		—		Other noncurrent liabilities
Total liabilities	$	802	$	8,956	$	—

XML

Pension and Other Postretirement Benefits (Tables)

3 Months Ended

Mar. 31, 2021

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Benefit Cost (Income)

Components of net periodic benefit cost (income) were as follows: 

	Pension Benefits				Postretirement Benefits
	Three months ended March 31,
(in thousands)	2021		2020		2021		2020
Components of net periodic benefit cost
Service cost	$	2,135	$	2,316	$	162	$	171
Interest cost	1,951		2,512		75		112
Expected return on plan assets	(2,547)		(2,903)		—		—
Settlement expense	1,419		—		—		—
Amortization of net loss (gain)	1,421		964		(65)		(214)
Amortization of prior service cost (credit)	71		70		(34)		(34)
Net periodic benefit cost	$	4,450	$	2,959	$	138	$	35

XML

Common Stock (Tables)

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of Declared Dividends Per Share

The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:

	Dividends per Common Share		Amount (in thousands)
2021:
First Quarter	$	0.165	$	12,767
Total dividends declared in 2021	$	0.165	$	12,767
2020:
Fourth Quarter	$	0.155	$	11,983
Third Quarter	0.155		11,790
Second Quarter	0.155		11,761
First Quarter	0.155		11,735
Total dividends declared in 2020	$	0.620	$	47,269

Schedule of Share Repurchase Activity

The Company's share repurchase activity was as follows:

	Three months ended March 31,
(in thousands, except share and per share amounts)	2021		2020
Shares repurchased in the open market:
Shares repurchased	56,156		243,894
Average price	$	42.34	$	28.60
Aggregate value	$	2,377	$	6,976

XML

Equity Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Summary of Restricted and Performance Stock Units

A summary of the Company’s RSUs and PSUs as of March 31, 2021 and changes during the three months then ended is presented below: 

		Weighted-			Weighted-
	Number	Average		Number	Average
	of RSUs	Fair Value RSUs		of PSUs	Fair Value PSUs
Outstanding as of December 31, 2020	1,253,173	$	24.33	457,576	$	24.55
Granted	289,259	45.36		145,110	45.36
Vested (1)	(362,605)	24.11		—	—
Forfeited	(20,290)	24.24		(2,631)	25.45
Outstanding as of March 31, 2021	1,159,537	$	29.65	600,055	$	29.58

_______________________________________________________________________________

(1) Includes 110,514 shares of common stock related to RSUs and no shares of common stock related to PSUs that were not delivered as of March 31, 2021.

Summary of Shares of Common Stock Issued

A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:

	Three months ended		Three months ended
	March 31, 2021		March 31, 2020
	RSUs	PSUs	RSUs	PSUs
Shares of common stock issued	270,779	—	42,797	—
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations	(89,938)	—	(13,831)	—
Net shares of common stock issued	180,841	—	28,966	—
Cumulative undelivered shares of common stock	395,670	—	240,512	—

Compensation Expense Recorded in the Consolidated Statement of Operations

Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
RSUs	$	2,359	$	2,478
PSUs	3,010		(455)

Schedule of Compensation Expense Related to Equity Incentive Plans

The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:

	Three months ended
	March 31,
(in thousands)	2021		2020
Cost of goods sold	$	(7)	$	225
Selling, general and administrative	5,381		1,714
Research and development	159		248
Total compensation expense before income tax	5,533		2,187
Income tax benefit	1,267		463
Total compensation expense, net of income tax	$	4,266	$	1,724

XML

Accumulated Other Comprehensive Loss, Net of Tax (Tables)

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects

The components of and changes in accumulated other comprehensive loss, net of tax, were as follows:

	Foreign		Gains (Losses) on		Gains (Losses) on		Pension and		Accumulated
	Currency		Foreign Exchange		Interest Rate		Other		Other
	Translation		Derivative		Swap Derivative		Postretirement		Comprehensive
(in thousands)	Adjustments		Instruments		Instruments		Adjustments		Loss, Net of Tax
Balance as of December 31, 2020	$	(43,906)	$	(4,471)	$	(1,179)	$	(46,626)	$	(96,182)
Other comprehensive income (loss) before reclassifications	(7,080)		4,376		(9)		(237)		(2,950)
Amounts reclassified from accumulated other comprehensive loss, net of tax	—		(396)		959		2,812		3,375
Tax expense	—		(1,435)		(229)		(739)		(2,403)
Balance as of March 31, 2021	$	(50,986)	$	(1,926)	$	(458)	$	(44,790)	$	(98,160)

XML

Net Income per Common Share (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Income Per Common Share

The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:

	Three months ended
	March 31,
(in thousands, except share and per share amounts)	2021		2020
Net income attributable to Acushnet Holdings Corp.	$	84,958	$	8,877
Weighted average number of common shares:
Basic	74,778,189		74,545,280
Diluted	75,255,312		75,099,930
Net income per common share attributable to Acushnet Holdings Corp.:
Basic	$	1.14	$	0.12
Diluted	$	1.13	$	0.12

Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares

For the three months ended March 31, 2021 and 2020, the following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:

	Three months ended
	March 31,
	2021	2020
RSUs	291,484	—

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts

Information by reportable segment and a reconciliation to reported amounts are as follows:

	Three months ended March 31,
(in thousands)	2021		2020
Net sales
Titleist golf balls	$	173,637	$	116,239
Titleist golf clubs	155,827		93,214
Titleist golf gear	53,120		43,525
FootJoy golf wear	159,434		130,387
Other	38,867		25,376
Total net sales	$	580,885	$	408,741
Segment operating income
Titleist golf balls	$	34,317	$	3,243
Titleist golf clubs	41,799		4,503
Titleist golf gear	9,728		8,865
FootJoy golf wear	28,117		14,297
Other	6,471		1,080
Total segment operating income	120,432		31,988
Reconciling items:
Interest expense, net	(3,616)		(4,123)
Restructuring charges	—		(11,628)
Non-service cost component of net periodic benefit cost	(2,291)		(507)
Other	(64)		885
Total income before income tax	$	114,461	$	16,615

Schedule of Net Sales By Geographical Area

Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.

	Three months ended March 31,
(in thousands)	2021		2020
United States	$	308,636	$	211,008
EMEA (1)	80,575		74,671
Japan	56,377		37,556
Korea	79,097		50,449
Rest of world	56,200		35,057
Total net sales	$	580,885	$	408,741

_______________________________________________________________________________

(1) Europe, the Middle East and Africa ("EMEA")

XML

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Schedule of Purchase Obligations

The Company's purchase obligations as of March 31, 2021 were as follows:

	Payments Due by Period
	Remainder of
(in thousands)	2021		2022		2023		2024		2025		Thereafter
Purchase obligations (1)	$	200,097	$	16,026	$	3,282	$	2,545	$	2,549	$	1,284

_______________________________________________________________________________

(1)    The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2021.

XML

Restructuring and Related Activities (Tables)

3 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

Schedule of Company's Restructuring Programs

The activity related to the Company’s restructuring programs was as follows:

	Three months ended March 31, 2021
(in thousands)	VBR		Other
Balance at beginning of period	$	6,243	$	778
Payments	(2,161)		(565)
Foreign currency translation and other	—		(1)
Balance at end of period	$	4,082	$	212

The restructuring program liabilities recognized on the unaudited condensed consolidated balance sheets were as follows:

(in thousands)		March 31,		December 31,
Balance Sheet Location	Restructuring Program	2021		2020
Accrued compensation and benefits	VBR	$	4,039	$	6,018
	Other	212		778
Other noncurrent liabilities	VBR	43		225

XML

Summary of Significant Accounting Policies - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Loan to minority shareholders included in temporary equity	$ 4,400,000	$ 4,400,000
Restricted cash	2,000,000.0	2,000,000.0
Transaction gains (losses) included in selling, general and administrative expense	$ (1,000,000.0)
VIE
Variable Interest Entity [Line Items]
Ownership percentage	40.00%
Outstanding borrowings	$ 0	$ 0

XML

Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ 7,698	$ 5,338
Bad debt (recovery) expense	(445)	916
Amount of receivables written off	(144)	(286)
Foreign currency translation and other	(32)	(186)
Balance at end of period	$ 7,077	$ 5,782

XML

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 73,080	$ 74,302
Work-in-process	25,077	22,913
Finished goods	232,008	260,467
Inventories	$ 330,165	$ 357,682

XML

Product Warranty (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Activity for accrued warranty expense
Balance at beginning of period	$ 3,831	$ 4,048
Provision	1,029	1,209
Claims paid/costs incurred	(918)	(944)
Foreign currency translation and other	(43)	(164)
Balance at end of period	$ 3,899	$ 4,149
Minimum
Product Warranty Liability [Line Items]
Product warranty period	1 year
Maximum
Product Warranty Liability [Line Items]
Product warranty period	2 years

XML

Debt and Financing Arrangements (Details)	Jul. 03, 2020	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Unsecured local credit facilities
Line of Credit Facility [Line Items]
Weighted average interest rate		0.28%	2.00%
Available borrowings		$ 50,300,000
Other short-term borrowings, outstanding borrowings		8,800,000	$ 2,800,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Outstanding borrowings		$ 15,900,000	0
Weighted average interest rate		1.79%
Available borrowings		$ 376,000,000.0
Letters of credit outstanding		8,100,000
Unamortized fees and expenses		700,000
Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Leverage ratio basis spread	0.15%
Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Leverage ratio basis spread	0.30%
Letters of Credit
Line of Credit Facility [Line Items]
Outstanding borrowings		11,800,000	11,700,000
Line of credit secured		8,600,000	$ 8,300,000
Maximum commitment		$ 53,700,000
Bridge Loan | Fed Funds Effective Rate Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Variable rate of interest	0.50%
Line of Credit
Line of Credit Facility [Line Items]
Initial commitment fee rate	0.20%
Secured leverage ratio	3.50
Increase in leverage ratio	3.75
Interest coverage ratio	3.00
Line of Credit | Minimum
Line of Credit Facility [Line Items]
Variable rate of interest	0.00%
Line of Credit | Maximum
Line of Credit Facility [Line Items]
Variable rate of interest	0.75%
Line of Credit | Canadian Dollar Offered Rate Cdor
Line of Credit Facility [Line Items]
Variable rate of interest	1.00%
Line of Credit | Canadian Dollar Offered Rate Cdor | Minimum
Line of Credit Facility [Line Items]
Leverage ratio basis spread	1.00%
Line of Credit | Canadian Dollar Offered Rate Cdor | Maximum
Line of Credit Facility [Line Items]
Leverage ratio basis spread	1.75%

XML

Derivative Instruments and Hedging Activities - Narrative (Details)	3 Months Ended
	Mar. 31, 2021 USD ($) derivative	Dec. 31, 2020 USD ($) derivative
Foreign exchange forward
Derivatives, Fair Value [Line Items]
Expected reclassification of gain (loss) recorded in accumulated other comprehensive loss, net of tax into cost of goods sold during next twelve months	$ (3,200,000)
Foreign exchange forward | Derivative designated as hedging
Derivatives, Fair Value [Line Items]
Notional amount	219,000,000.0	$ 248,100,000
Foreign exchange forward | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional amount of hedges deemed ineffective	$ 0	$ 0
Number of outstanding contracts | derivative	0	0
Foreign exchange forward | Maximum
Derivatives, Fair Value [Line Items]
Term of derivative contract	24 months
Interest rate swap
Derivatives, Fair Value [Line Items]
Expected reclassification of gain (loss) recorded in accumulated other comprehensive loss, net of tax into cost of goods sold during next twelve months	$ (600,000)
Interest rate swap | Derivative designated as hedging
Derivatives, Fair Value [Line Items]
Notional amount	$ 140,000,000.0	$ 140,000,000.0

XML

Derivative Financial Instruments - Fair Value of Hedge Instruments in Unaudited Condensed Consolidated Balance Sheets (Details) - Derivative Designated as Hedging - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Foreign exchange forward | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Asset derivatives	$ 3,476	$ 1,166
Foreign exchange forward | Other assets
Derivatives, Fair Value [Line Items]
Asset derivatives	1,225	30
Foreign exchange forward | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	3,929	6,400
Foreign exchange forward | Other noncurrent liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	92	985
Interest rate swap | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	$ 621	$ 1,571

XML

Derivative Instruments and Hedging Activities - Effect of Hedge Instruments in Unaudited Condensed Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized holding gains arising during period	$ 4,367	$ 7,402
Cash flow hedge | Derivative designated as hedging
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized holding gains arising during period	4,367	7,402
Foreign exchange forward | Cash flow hedge | Derivative designated as hedging
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized holding gains arising during period	4,376	9,467
Interest rate swap | Cash flow hedge | Derivative designated as hedging
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized holding gains arising during period	$ (9)	$ (2,065)

XML

Derivative Financial Instruments - Effect of Hedge Instruments in Unaudited Condensed Comprehensive Income (Loss) And Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Net gain reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective	$ (563)	$ 1,724
Derivative designated as hedging | Foreign exchange forward
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on unaudited condensed consolidated statements of operations	1,036	3,076
Derivative designated as hedging | Foreign exchange forward | Cost of goods sold
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on unaudited condensed consolidated statements of operations	396	1,542
Derivative designated as hedging | Foreign exchange forward | Selling, general and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on unaudited condensed consolidated statements of operations	640	1,534
Net gain reclassified out of accumulated other comprehensive loss, net of tax related to hedges deemed ineffective		700
Derivative designated as hedging | Interest rate swap
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on unaudited condensed consolidated statements of operations	(959)	(478)
Derivative designated as hedging | Interest rate swap | Interest expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on unaudited condensed consolidated statements of operations	$ (959)	$ (478)

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Level 1
Assets
Total assets	$ 5,849	$ 5,962
Liabilities
Total liabilities	803	802
Level 2
Assets
Total assets	4,701	1,196
Liabilities
Total liabilities	4,642	8,956
Level 3
Assets
Total assets	0	0
Liabilities
Total liabilities	0	0
Prepaid and other assets | Level 1
Assets
Rabbi trust	5,046	5,160
Prepaid and other assets | Level 2
Assets
Rabbi trust	0	0
Prepaid and other assets | Level 3
Assets
Rabbi trust	0	0
Prepaid and other assets | Foreign exchange derivative instruments | Level 1
Assets
Derivative instruments	0	0
Prepaid and other assets | Foreign exchange derivative instruments | Level 2
Assets
Derivative instruments	3,476	1,166
Prepaid and other assets | Foreign exchange derivative instruments | Level 3
Assets
Derivative instruments	0	0
Other assets | Level 1
Assets
Deferred compensation program assets	803	802
Other assets | Level 2
Assets
Deferred compensation program assets	0	0
Other assets | Level 3
Assets
Deferred compensation program assets	0	0
Other assets | Foreign exchange derivative instruments | Level 1
Assets
Derivative instruments	0	0
Other assets | Foreign exchange derivative instruments | Level 2
Assets
Derivative instruments	1,225	30
Other assets | Foreign exchange derivative instruments | Level 3
Assets
Derivative instruments	0	0
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 1
Liabilities
Derivative instruments	0	0
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 2
Liabilities
Derivative instruments	3,929	6,400
Accrued expenses and other liabilities | Foreign exchange derivative instruments | Level 3
Liabilities
Derivative instruments	0	0
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 1
Liabilities
Derivative instruments	0	0
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 2
Liabilities
Derivative instruments	621	1,571
Accrued expenses and other liabilities | Interest rate derivative instruments | Level 3
Liabilities
Derivative instruments	0	0
Other noncurrent liabilities | Level 1
Liabilities
Deferred compensation program liabilities	803	802
Other noncurrent liabilities | Level 2
Liabilities
Deferred compensation program liabilities	0	0
Other noncurrent liabilities | Level 3
Liabilities
Deferred compensation program liabilities	0	0
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 1
Liabilities
Derivative instruments	0	0
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 2
Liabilities
Derivative instruments	92	985
Other noncurrent liabilities | Foreign exchange derivative instruments | Level 3
Liabilities
Derivative instruments	$ 0	$ 0

XML

Pension and Other Postretirement Benefits (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Pension Benefits
Components of net periodic benefit cost
Service cost	$ 2,135	$ 2,316
Interest cost	1,951	2,512
Expected return on plan assets	(2,547)	(2,903)
Settlement expense	1,419	0
Amortization of net loss (gain)	1,421	964
Amortization of prior service cost (credit)	71	70
Net periodic benefit cost	4,450	2,959
Postretirement Benefits
Components of net periodic benefit cost
Service cost	162	171
Interest cost	75	112
Expected return on plan assets	0	0
Settlement expense	0	0
Amortization of net loss (gain)	(65)	(214)
Amortization of prior service cost (credit)	(34)	(34)
Net periodic benefit cost	$ 138	$ 35

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Increase (decrease) in income tax expense	$ 20,200
Income tax expense	$ 27,834	$ 7,640
Effective tax rate	24.30%	46.00%

XML

Common Stock - Dividends and Share Repurchase Program (Details) - USD ($)		3 Months Ended					12 Months Ended
	Apr. 02, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2020	May 06, 2021
Equity [Abstract]
Dividends per Common Share (in dollars per share)		$ 0.165	$ 0.155	$ 0.155	$ 0.155	$ 0.155	$ 0.620
Amount		$ 12,767,000	$ 11,983,000	$ 11,790,000	$ 11,761,000	$ 11,735,000	$ 47,269,000
Dividends Payable [Line Items]
Issued and outstanding common stock authorized to repurchase		$ 100,000,000.0
Accrued share repurchase (in shares)		355,341	299,894				299,894
Amount remaining under current authorizations		$ 61,300,000
Aggregate value		2,377,000				$ 6,976,000
Subsequent Event
Dividends Payable [Line Items]
Dividends declared and payable (in dollars per share)								$ 0.165
Magnus
Dividends Payable [Line Items]
Stock repurchase program, authorized amount		24,900,000
Share repurchase liability		$ 11,100,000	$ 8,800,000				$ 8,800,000
Accrued share repurchase (in shares)		355,341	299,894				299,894
Amount remaining under current authorizations		$ 11,100,000
Aggregate purchases of shares in open market before shares will be purchased from Magnus		$ 24,900,000
Magnus | Subsequent Event
Dividends Payable [Line Items]
Shares repurchased (in shares)	355,341
Aggregate value	$ 11,100,000

XML

Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Dividends Payable [Line Items]
Aggregate value	$ 2,377	$ 6,976
Open Market
Dividends Payable [Line Items]
Shares repurchased (in shares)	56,156	243,894
Average price (in dollars per share)	$ 42.34	$ 28.60
Aggregate value	$ 2,377	$ 6,976

XML

Equity Incentive Plans - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 23.4
Weighted average period	2 years 3 months 18 days
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Unrecognized compensation expense	$ 13.0
Weighted average period	2 years 2 months 12 days
Minimum | PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
Maximum | PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
Company officers | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Vesting percentage	33.33%
Officers, employees, consultants and advisors | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

XML

Equity Incentive Plans - Restricted Stock and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan	3 Months Ended
	Mar. 31, 2021 $ / shares shares
RSUs
Number of Units
Outstanding at beginning of the period (in shares)	1,253,173
Granted (in shares)	289,259
Vested (in shares)	(362,605)
Forfeited (in shares)	(20,290)
Outstanding at end of the period (in shares)	1,159,537
Weighted - Average Fair Value
Outstanding at beginning of the period (in dollars per share) | $ / shares	$ 24.33
Granted (in dollars per share) | $ / shares	45.36
Vested (in dollars per share) | $ / shares	24.11
Forfeited (in dollars per share) | $ / shares	24.24
Outstanding at end of the period (in dollars per share) | $ / shares	$ 29.65
Undelivered (in shares)	110,514
PSUs
Number of Units
Outstanding at beginning of the period (in shares)	457,576
Granted (in shares)	145,110
Vested (in shares)	0
Forfeited (in shares)	(2,631)
Outstanding at end of the period (in shares)	600,055
Weighted - Average Fair Value
Outstanding at beginning of the period (in dollars per share) | $ / shares	$ 24.55
Granted (in dollars per share) | $ / shares	45.36
Vested (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	25.45
Outstanding at end of the period (in dollars per share) | $ / shares	$ 29.58
Undelivered (in shares)	0

XML

Equity Incentive Plans - Summary of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
RSUs
Class of Stock [Line Items]
Cumulative undelivered shares of common stock (in shares)	110,514
PSUs
Class of Stock [Line Items]
Cumulative undelivered shares of common stock (in shares)	0
Common Stock | RSUs
Class of Stock [Line Items]
Shares of common stock issued (in shares)	270,779	42,797
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares)	(89,938)	(13,831)
Net shares of common stock issued (in shares)	180,841	28,966
Cumulative undelivered shares of common stock (in shares)	395,670	240,512
Common Stock | PSUs
Class of Stock [Line Items]
Shares of common stock issued (in shares)	0	0
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares)	0	0
Net shares of common stock issued (in shares)	0	0
Cumulative undelivered shares of common stock (in shares)	0	0

XML

Equity Incentive Plans - Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 5,533	$ 2,187
RSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	2,359	2,478
PSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 3,010	$ (455)

XML

Equity Incentive Plans - Allocation of Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	$ 5,533	$ 2,187
Income tax benefit	1,267	463
Total compensation expense, net of income tax	4,266	1,724
Cost of goods sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	(7)	225
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	5,381	1,714
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	$ 159	$ 248

XML

Accumulated Other Comprehensive Loss, Net of Tax (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,017,253
Other comprehensive income (loss) before reclassifications	(2,950)
Amounts reclassified from accumulated other comprehensive loss, net of tax	3,375
Tax expense	(2,403)
Ending balance	1,085,980
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(43,906)
Other comprehensive income (loss) before reclassifications	(7,080)
Amounts reclassified from accumulated other comprehensive loss, net of tax	0
Tax expense	0
Ending balance	(50,986)
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(4,471)
Other comprehensive income (loss) before reclassifications	4,376
Amounts reclassified from accumulated other comprehensive loss, net of tax	(396)
Tax expense	(1,435)
Ending balance	(1,926)
Gains (Losses) on Derivative Instruments | Interest Rate Swap Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(1,179)
Other comprehensive income (loss) before reclassifications	(9)
Amounts reclassified from accumulated other comprehensive loss, net of tax	959
Tax expense	(229)
Ending balance	(458)
Pension and Other Postretirement Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(46,626)
Other comprehensive income (loss) before reclassifications	(237)
Amounts reclassified from accumulated other comprehensive loss, net of tax	2,812
Tax expense	(739)
Ending balance	(44,790)
Accumulated Other Comprehensive Loss, Net of Tax
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(96,182)
Ending balance	$ (98,160)

XML

Net Income per Common Share - Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Net income attributable to Acushnet Holdings Corp.	$ 84,958	$ 8,877
Weighted average number of common shares:
Basic (in shares)	74,778,189	74,545,280
Diluted (in shares)	75,255,312	75,099,930
Net income per common share attributable to Acushnet Holdings Corp.:
Basic (in dollars per share)	$ 1.14	$ 0.12
Diluted (in dollars per share)	$ 1.13	$ 0.12

XML

Net Income per Common Share - Calculation of Diluted Weighted Average Common Shares Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
RSUs
Securities excluded from calculation of diluted weighted-average common shares outstanding as their impact was anti-dilutive (in shares)	291,484	0

XML

Segment Information - Reconciliation (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($) segment	Mar. 31, 2020 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	4
Segment Reporting Information [Line Items]
Total net sales	$ 580,885	$ 408,741
Segment operating income	120,069	21,428
Reconciling items:
Interest expense, net	(3,616)	(4,123)
Restructuring charges	0	(11,628)
Income before income taxes	114,461	16,615
Other
Segment Reporting Information [Line Items]
Total net sales	38,867	25,376
Segment operating income	6,471	1,080
Operating segments and other
Segment Reporting Information [Line Items]
Segment operating income	120,432	31,988
Reconciling Items
Reconciling items:
Interest expense, net	(3,616)	(4,123)
Restructuring charges	0	(11,628)
Non-service cost component of net periodic benefit cost	(2,291)	(507)
Other	(64)	885
Titleist golf balls | Operating segments
Segment Reporting Information [Line Items]
Total net sales	173,637	116,239
Segment operating income	34,317	3,243
Titleist golf clubs | Operating segments
Segment Reporting Information [Line Items]
Total net sales	155,827	93,214
Segment operating income	41,799	4,503
Titleist golf gear | Operating segments
Segment Reporting Information [Line Items]
Total net sales	53,120	43,525
Segment operating income	9,728	8,865
FootJoy golf wear | Operating segments
Segment Reporting Information [Line Items]
Total net sales	159,434	130,387
Segment operating income	$ 28,117	$ 14,297

XML

Segment Information - Geographical Areas (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 580,885	$ 408,741
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	308,636	211,008
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	80,575	74,671
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	56,377	37,556
Korea
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	79,097	50,449
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 56,200	$ 35,057

XML

Commitments and Contingencies - Purchase Commitments (Details) $ in Thousands	Mar. 31, 2021 USD ($)
Payments Due by Period
Remainder of 2021	$ 200,097
2022	16,026
2023	3,282
2024	2,545
2025	2,549
Thereafter	$ 1,284

XML

Restructuring Charges - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0	$ 11,628,000
Restructuring and related costs expected	$ 0
VBR
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred to date		11,200,000
Restructuring charges		11,200,000
Other restructuring program
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred to date		2,000,000.0
Restructuring charges		$ 400,000

XML

Restructuring Charges - Schedule of Company's Restructuring Program Rollforward (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
VBR
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 6,243
Payments	(2,161)
Foreign currency translation and other	0
Balance at end of period	4,082
Other
Restructuring Reserve [Roll Forward]
Balance at beginning of period	778
Payments	(565)
Foreign currency translation and other	(1)
Balance at end of period	$ 212

XML

Restructuring Charges - Restructuring Liabilities Recognized on Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
VBR | Accrued compensation and benefits
Restructuring Cost and Reserve [Line Items]
Accrued compensation and benefits	$ 4,039	$ 6,018
VBR | Other noncurrent liabilities
Restructuring Cost and Reserve [Line Items]
Other noncurrent liabilities	43	225
Other | Accrued compensation and benefits
Restructuring Cost and Reserve [Line Items]
Accrued compensation and benefits	$ 212	$ 778